Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2018 | May 01, 2018 | |
Entity Information [Line Items] | ||
Entity Registrant Name | MAXLINEAR INC | |
Trading Symbol | MXL | |
Entity Central Index Key | 1,288,469 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2018 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 68,121,491 | |
Entity Well-known Seasoned Issuer | No | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | Yes |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Current assets: | ||
Cash and cash equivalents | $ 55,645 | $ 71,872 |
Short-term restricted cash | 617 | 1,476 |
Accounts receivable, net | 90,632 | 66,099 |
Inventory | 45,758 | 53,434 |
Prepaid expenses and other current assets | 8,413 | 8,423 |
Total current assets | 201,065 | 201,304 |
Long-term restricted cash | 1,071 | 1,064 |
Property and equipment, net | 21,993 | 22,658 |
Intangible assets, net | 298,031 | 315,045 |
Deferred Tax Assets, Net, Noncurrent | 41,426 | 39,878 |
Other long-term assets | 7,318 | 6,921 |
Total assets | 808,714 | 824,862 |
Current liabilities: | ||
Accounts payable | 12,363 | 16,939 |
Deferred revenue and deferred profit | 0 | 4,362 |
Accrued price protection liability | 20,212 | 21,571 |
Accrued expenses and other current liabilities | 25,713 | 20,306 |
Accrued compensation | 8,773 | 13,208 |
Total current liabilities | 67,061 | 76,386 |
Deferred rent | 4,718 | 4,885 |
Unsecured Long-term Debt, Noncurrent | 322,896 | 347,609 |
Other long-term liabilities | 7,591 | 8,558 |
Total liabilities | 402,266 | 437,438 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Common stock | 7 | 7 |
Additional paid-in capital | 469,556 | 455,497 |
Accumulated other comprehensive income | 2,628 | 1,039 |
Accumulated deficit | (65,743) | (69,119) |
Total stockholders’ equity | 406,448 | 387,424 |
Total liabilities and stockholders’ equity | $ 808,714 | $ 824,862 |
Consolidated Balance Sheet (Par
Consolidated Balance Sheet (Parenthetical) - $ / shares | Mar. 31, 2018 | Dec. 31, 2017 |
Preferred stock, par value (usd per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (shares) | 25,000,000 | 25,000,000 |
Preferred stock, shares issued (shares) | 0 | 0 |
Preferred stock, shares outstanding (shares) | 0 | 0 |
Common Stock [Member] | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 550,000,000 | 550,000,000 |
Common stock, shares issued (shares) | 68,091,000 | 67,400,000 |
Common stock, shares outstanding (shares) | 68,091,000 | 67,400,000 |
Common Class A [Member] | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 441,124,000 | 441,124,000 |
Common stock, shares issued (shares) | 0 | 0 |
Common stock, shares outstanding (shares) | 0 | 0 |
Common Class B [Member] | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 493,430,000 | 493,430,000 |
Common stock, shares issued (shares) | 0 | 0 |
Common stock, shares outstanding (shares) | 0 | 0 |
Consolidated Statement of Opera
Consolidated Statement of Operations - USD ($) shares in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Net revenue | $ 110,827,000 | $ 88,841,000 |
Cost of net revenue | 48,159,000 | 35,917,000 |
Gross profit | 62,668,000 | 52,924,000 |
Operating expenses: | ||
Research and development | 31,121,000 | 23,878,000 |
Selling, general and administrative | 27,117,000 | 18,613,000 |
IPR&D impairment losses | 0 | |
Total operating expenses | 58,238,000 | 42,491,000 |
Income from operations | 4,430,000 | 10,433,000 |
Interest income | 18,000 | 195,000 |
Interest Expense | (3,894,000) | (1,000) |
Other expense, net | (571,000) | (143,000) |
Total interest and other income (expense), net | (4,447,000) | 51,000 |
Income (loss) before income taxes | (17,000) | 10,484,000 |
Income tax provision (benefit) | (1,864,000) | 2,021,000 |
Net income (loss) | $ 1,847,000 | $ 8,463,000 |
Net income per share: | ||
Basic | $ 0.03 | $ 0.13 |
Diluted | $ 0.03 | $ 0.12 |
Shares used to compute net income per share: | ||
Diluted | 70,440 | 69,149 |
Consolidated Statement of Compr
Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | ||
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ 1,847 | $ 8,463 | |
Other comprehensive income (loss), net of tax: | |||
Unrealized loss on investments, net of tax of $0 for the three months ended March 31, 2018 and 2017 | 0 | (17) | |
Foreign currency translation adjustments, net of tax benefit of $29 and $35 for the three months ended March 31, 2018 and 2017, respectively(1) | [1] | 393 | 370 |
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax | 1,196 | 0 | |
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax | 188 | 0 | |
Other comprehensive income | 1,589 | 353 | |
Total comprehensive income | $ 3,436 | $ 8,816 | |
[1] | (1) Tax amount recognized in Other Long-Term Liabilities on the Consolidated Balance Sheets as part of long-term deferred tax liabilities. |
Consolidated Statement of Comp6
Consolidated Statement of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Statement of Comprehensive Income [Abstract] | ||
Other comprehensive income (loss), Unrealized Holding Gain (Loss) on Securities Arising During the Period, tax | $ 0 | $ 0 |
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax | 0 | 0 |
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax | 29 | 35 |
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax | $ 188 | $ 0 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Net income (loss) | $ 1,847,000 | $ 8,463,000 |
Adjustments to reconcile net income to cash provided by operating activities: | ||
Amortization and depreciation | 20,084,000 | 6,899,000 |
Impairment of IPR&D assets | 0 | |
Provision for losses on accounts receivable | 0 | 87,000 |
Amortization of investment premiums | 0 | 47,000 |
Amortization of Debt Issuance Costs and Discounts | 287,000 | 0 |
Stock-based compensation | 8,473,000 | 5,474,000 |
Deferred income taxes | (2,332,000) | 155,000 |
Gain on disposal of property and equipment | 0 | (88,000) |
(Gain) loss on foreign currency | 471,000 | (216,000) |
Excess tax benefits on stock-based awards | (797,000) | (914,000) |
Changes in operating assets and liabilities: | ||
Accounts receivable | (24,533,000) | (7,436,000) |
Inventory | 7,676,000 | (5,102,000) |
Prepaid expenses and other assets | 1,003,000 | 825,000 |
Accounts payable, accrued expenses and other current liabilities | (421,000) | 7,952,000 |
Accrued compensation | 2,502,000 | 382,000 |
Deferred revenue and deferred profit | (138,000) | (307,000) |
Accrued price protection liability | (1,359,000) | 6,771,000 |
Other long-term liabilities | (792,000) | (320,000) |
Net cash provided by operating activities | 11,971,000 | 22,672,000 |
Investing Activities | ||
Purchases of property and equipment | (2,381,000) | (743,000) |
Purchases of intangible assets | 0 | (120,000) |
Purchases of available-for-sale securities | 0 | (30,577,000) |
Maturities of available-for-sale securities | 0 | 20,785,000 |
Net cash used in investing activities | (2,381,000) | (10,655,000) |
Financing Activities | ||
Repurchases of common stock | 0 | (334,000) |
Net proceeds from issuance of common stock | 980,000 | 361,000 |
Minimum tax withholding paid on behalf of employees for restricted stock units | (2,391,000) | (4,903,000) |
Repayments of Secured Debt | (25,000,000) | 0 |
Net cash used in financing activities | (26,411,000) | (4,876,000) |
Effect of exchange rate changes on cash and cash equivalents | (258,000) | 1,201,000 |
Increase (decrease) in cash, cash equivalents and restricted cash | (17,079,000) | 8,342,000 |
Cash, cash equivalents and restricted cash at beginning of period | 74,412,000 | 82,896,000 |
Cash, cash equivalents and restricted cash at end of period | 57,333,000 | 91,238,000 |
Supplemental disclosures of cash flow information: | ||
Cash paid for interest | 3,546,000 | 0 |
Cash paid for income taxes | 203,000 | 421,000 |
Issuance of accrued share-based bonus plan | 6,997,000 | 3,314,000 |
Physpeed [Member] | ||
Supplemental disclosures of cash flow information: | ||
Issuance of restricted stock units to Physpeed continuing employees | $ 0 | $ 861,000 |
Organization and Summary of Sig
Organization and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Summary of Significant Accounting Policies | Organization and Summary of Significant Accounting Policies Description of Business MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its wholly owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of radio-frequency, or RF, high-performance analog, and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear's customers include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices, including cable DOCSIS broadband modems and gateways, wireline connectivity devices for in-home networking applications, RF transceivers and modems for wireless carrier access and backhaul infrastructure, fiber-optic modules for data center, metro, and long-haul transport networks, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products used in these and a range of other markets. The Company is a fabless integrated circuit design company whose products integrate all or a substantial portions of a broadband communication system. Basis of Presentation and Principles of Consolidation The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation. In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income and cash flows. The consolidated balance sheet as of December 31, 2017 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on February 20, 2018, or the Annual Report. Interim results for the three months ended March 31, 2018 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2018 . Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to unaudited consolidated financial statements. Actual results could differ from those estimates. Summary of Significant Accounting Policies Refer to the Company’s Annual Report for a summary of significant accounting policies. On January 1, 2018, the Company adopted Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 606, Revenue from Contracts with Customers , or ASC 606 and accordingly, modified its policy on revenue recognition as stated below . The primary impact of adopting ASC 606 for the Company was to accelerate the timing of the Company’s revenue and related cost recognition on products sold via some of its distributors, which changed from recognition upon the sale to the distributors' end customers, or the sell-through method, to recognition upon the Company's sale to the distributor, or the sell-in method. The Company is now also required to estimate the effects of pricing credits to its distributors from contractual price protection and unit rebate provisions, as well as stock rotation rights and record such estimated credits upon the Company's sale to the distributor. There have been no other material changes to our significant accounting policies during the three months ended March 31, 2018 . Revenue Recognition All of the Company's revenue is generated from sales of the Company’s integrated circuits to electronics distributors, module makers, OEMs, and ODMs under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product sales. Effective January 1, 2018, the Company adopted ASC 606 and recognizes revenue at the point in time when control of the products is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer's rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company's product sales, transfer of control occurs upon shipment to the distributor or direct customer. In assessing whether collection of consideration from a customer is probable, the Company considers the customer's ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component. A five-step approach is applied in the recognition of revenue under ASC 606: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. The Company applied ASC 606 to its customer contracts that were not completed before the January 1, 2018 adoption date. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach under ASC 606. Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time of control transfers using the expected value method based on the Company's analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company's sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company's current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company's general assurance warranty of products for a period of one to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company's customers resell our product as part of their product and thus are tax-exempt; however, to the extent the Company collects and remits taxes on product sales form customers, it has elected to exclude from the measurement of transaction price such taxes. Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has opted to not disclose the portion of revenues allocated to partially unsatisfied performance obligations, which represent products to be shipped within 12 months under open customer purchase orders, at the end of the current reporting period as allowed under ASC 606. The Company has also elected to record sales commissions when incurred, pursuant to the practical expedient under ASC 340, as the period over which the sales commission asset that would have been recognized is less than one year. Customer contract liabilities consist of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers consist of estimates of price protection rights offered to the Company's end customers, which are included in accrued price protection liability in the consolidated balance sheets, as well as price adjustments expected to be claimed by the distributor upon sell-through of the products to their customers, and amounts expected to be returned by distributors under stock rotation rights, which are included in accrued expenses and other current liabilities in the consolidated balance sheets. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately one to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12 . The Company assesses customer accounts receivable for impairment in accordance with ASC 310-10-35. The following tables present the amounts by which each financial statement line item was affected as a result of applying ASC 606: Three Months Ended March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands, except per share amounts) Consolidated statement of income: Net revenue $ 97,481 $ 13,346 $ 110,827 Cost of net revenue 42,992 5,167 48,159 Gross profit 54,489 8,179 62,668 Income (loss) from operations (3,749 ) 8,179 4,430 Loss before income taxes (8,196 ) 8,179 (17 ) Income tax benefit (3,582 ) 1,718 (1,864 ) Net income (loss) (4,614 ) 6,461 1,847 Basic earnings (loss) per share (0.07 ) 0.10 0.03 Diluted earnings (loss) per share (0.07 ) 0.10 0.03 March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands) Consolidated balance sheet: Accounts receivable $ 91,604 $ (972 ) $ 90,632 Inventory 45,679 79 45,758 Total current assets 201,958 (893 ) 201,065 Total assets 809,607 (893 ) 808,714 Deferred revenue and deferred profit 20,159 (20,159 ) — Accrued expenses and other current liabilities 14,542 11,171 25,713 Total current liabilities 76,049 (8,988 ) 67,061 Total liabilities 411,254 (8,988 ) 402,266 Accumulated deficit (73,838 ) 8,095 (65,743 ) Total stockholders' equity 398,353 8,095 406,448 Total liabilities and stockholders' equity 809,607 (893 ) 808,714 The impacts of adopting ASC 606 as shown above were primarily related to the acceleration of the timing of the Company’s revenue and related cost recognition on products sold via some of its distributors, which changed from sale to the distributors' end customers, or the sell-through method, to recognition upon the Company's sale to the distributor, or the sell-in method. Revenues from sales through the Company’s distributors accounted for 39% and 23% of net revenue for the three months ended March 31, 2018 and 2017 , respectively. Restricted Cash As of March 31, 2018 and December 31, 2017 , the Company has restricted cash of $1.7 million and $2.5 million , respectively. The restricted cash is on deposit in connection with guarantees for certain import duties and office leases. Recently Adopted Accounting Pronouncements In May 2014, the FASB, issued Accounting Standards Update, or ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which provides for new accounting guidance related to revenue recognition. This new standard replaced all prior U.S. GAAP guidance on this topic and eliminated all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance became effective for the Company on January 1, 2018 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company applied the guidance prospectively with an adjustment to accumulated deficit for the cumulative effect of adoption. Adoption of the amendments in this guidance accelerated the timing of the Company’s revenue and related cost recognition on products sold via some distributors, which changed from the sell-through method to the sell-in method under this guidance. The Company is also required to estimate the effects of pricing credits to its distributors from contractual price protection and unit rebate provisions, as well as stock rotation rights. The Company has performed an assessment of the impact of adopting this new accounting standard on its consolidated financial position and results of operations. The impact of adoption of this new accounting standard for the year ending December 31, 2018 will vary depending on the level of inventory remaining at December 31, 2018 at distributors for which the Company previously recognized revenue on a sell-through basis, and therefore could have a material impact on the Company's revenues for the year ending December 31, 2018. The impact to accumulated deficit as of January 1, 2018 was not material. As a result of applying the guidance prospectively with an adjustment to accumulated deficit in the Company's consolidated financial statements for the cumulative effect of adoption, revenues that would have been recognized on a sell-through basis for the amount of deferred revenue and profit remaining as of the adoption date will not be recognized in earnings for any period. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities . The amendments in this update include, among other things, a requirement to (1) measure equity investments (except equity method investments) at fair value with changes in fair value recognized in net income, with an option to measure equity investments that do not have readily determinable fair values at cost minus any impairment plus or minus any changes resulting from observable price changes; previously changes in fair value were recognized in other comprehensive income, and (2) separately present financial assets and liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statement. The amendments in this update were effective for the Company beginning in the first quarter of fiscal year 2018. The adoption of the amendments in this update did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. In March 2016, the FASB issued ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net ) to clarify the revenue recognition implementation guidance on principal versus agent considerations. The amendments in this update clarify that when another party is involved in providing goods or services to a customer, an entity that is the principal has obtained control of a good or service before it is transferred to a customer, and provides indicators to assist an entity in determining whether it controls a specified good or service prior to the transfer to the customer. An entity that is the principal recognizes revenue in the gross amount of consideration to which it expects to be entitled in exchange for the specified good or service transferred to the customer, whereas an agent recognizes revenue in the amount of any fee or commission to which it expects to be entitled in exchange for arranging for the specified good or service to be provided by the other party. The amendments in this update were effective for the Company beginning in the first quarter of fiscal year 2018, concurrent with and applied on the same basis as the new revenue recognition standard. The adoption of the amendments in this update did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments to eliminate the diversity in practice regarding the presentation and classification of certain cash receipts and cash payments, including, among other things, contingent consideration payments made following a business combination, proceeds from the settlement of insurance claims in the statement of cash flows, and debt prepayment or debt extinguishment costs. Cash payments not made soon after the acquisition date up to the amount of the contingent consideration liability recognized at the acquisition date, with any excess payments classified as operating activities, whereas cash payments made soon after the acquisition date to settle the contingent consideration should be classified as investing activities and cash payments for debt prepayment or debt extinguishment costs should be classified as financing activities. Cash proceeds received from settlement of insurance claims should be classified on the basis of the nature of the related losses. The amendments in this update should be applied using a retrospective transition method to each period presented, unless impracticable, and if impracticable, would be applied prospectively as of the earliest date practicable. The amendments in this update were effective for fiscal years beginning with fiscal year 2018, including interim periods within those years. The adoption of the amendments in this update did not have a material impact on the Company's consolidated statements of cash flows for the three months ended March 31, 2018 . In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The amendments in this update require the Company to account for the effects of a modification in a stock-based award unless the fair value, vesting conditions and classification of the modified award is the same as those of the original award immediately before the original award is modified. If the modification does not affect any of the inputs to the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification. The amendments in this update were effective for the Company for fiscal years beginning with fiscal year 2018, including interim periods within those years, with early adoption permitted in any interim period. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. The adoption of this guidance did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act, or the Tax Act. The Tax Act makes broad and complex changes to the U.S. tax code. On December 22, 2017, the U.S. Securities and Exchange Commission Staff, or SEC Staff, issued guidance in Staff Accounting Bulletin No. 118, or SAB 118, to address certain fact patterns where the accounting for changes in tax laws or tax rates under ASC Topic 740 is incomplete upon issuance of an entity's financial statements for the reporting period in which the Tax Act is enacted. As permitted in SAB 118, in 2017, the Company took a measurement period approach and reported certain provisional amounts, based on reasonable estimates, for certain tax effects in which the accounting under ASC 740 is incomplete. Such provisional amounts are subject to adjustment during a limited measurement period, not to extend one year beyond the tax law enactment date, until the accounting under ASC 740 is complete. The Company also made required supplemental disclosures in the notes to the 2017 consolidated financial statements to accompany the provisional amounts, including the reasons for the incomplete accounting, the additional information or analysis that is needed, and other information relevant to why the Company was not able to complete the accounting required under ASC 740 in a timely manner. For adjustments to previously reported provisional amounts made in the three months ended March 31, 2018, refer to Note 10 . Additional adjustments to such reported provisional amounts could result in a material adverse impact to the Company's consolidated financial position and results of operations in 2018. In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. The amendments in this update are effective for the Company beginning in fiscal 2019, including interim periods. Early adoption is permitted. The amendments should be applied either in the period of adoption or retrospectively to each period or periods in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company elected to early adopt this guidance in the three months ended March 31, 2018. The adoption of this guidance did not have a material impact on the Company's consolidated financial position and results of operations. In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 . The amendments in this update amend the SEC paragraphs included in Topic 740 to be consistent with the guidance in SAB 118, which the Company adopted in the three months ended December 31, 2017, as described above. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments in this update require a lessee to recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term for all leases with terms greater than twelve months. For leases less than twelve months, an entity is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The Company intends to make this election. The amendments in this update are effective for the Company for fiscal years beginning with fiscal year 2019, including interim periods within those years, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption of the amendments in this update on the Company’s consolidated financial position and results of operations; however, adoption of the amendments in this update is expected to have a material impact on the Company's consolidated financial position. In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment , to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination. Instead, under the amendments in this update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Board also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendments in this update are effective for the Company beginning with fiscal year 2020, including interim periods, with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of the amendments in this update is not expected to have a material impact on the Company's consolidated financial position and results of operations. |
Net Income (Loss) Per Share
Net Income (Loss) Per Share | 3 Months Ended |
Mar. 31, 2018 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) Per Share | Net Income Per Share Basic earnings per share, or EPS, is calculated by dividing net income by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net income by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock options, restricted stock units and restricted stock awards are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS. The table below presents the computation of basic and diluted EPS: Three Months Ended March 31, 2018 2017 (in thousands, except per share amounts) Numerator: Net income $ 1,847 $ 8,463 Denominator: Weighted average common shares outstanding—basic 67,674 65,238 Dilutive common stock equivalents 2,766 3,911 Weighted average common shares outstanding—diluted 70,440 69,149 Net income per share: Basic $ 0.03 $ 0.13 Diluted $ 0.03 $ 0.12 The Company excluded 1.0 million and 0.4 million common stock equivalents for outstanding stock-based awards for the three months ended March 31, 2018 and 2017 , respectively, from the calculation of diluted net income per share due to their anti-dilutive nature. |
Business Combinations
Business Combinations | 3 Months Ended |
Mar. 31, 2018 | |
Business Combinations [Abstract] | |
Business Combinations | Business Combinations Acquisition of Exar Corporation On May 12, 2017 , pursuant to the March 28, 2017 Agreement and Plan of Merger, Eagle Acquisition Corporation, a Delaware corporation and wholly-owned subsidiary of MaxLinear, merged with and into Exar Corporation , or Exar, with Exar surviving as a wholly owned subsidiary of MaxLinear. Under this Agreement and Plan of Merger, the Company agreed to acquire all of Exar's outstanding common stock for $13.00 per share in cash. MaxLinear also assumed certain of Exar's stock-based awards in the merger. MaxLinear paid aggregate cash consideration of $688.1 million including $12.7 million of cash paid to settle certain stock-based awards that were not assumed by MaxLinear in the merger. The Company funded the transaction with cash from the balance sheet of the combined companies, including $235.8 million of cash from Exar, and the net proceeds of approximately $416.8 million from $425.0 million of new transaction debt (Note 8 ). Exar is a designer and developer of high-performance analog mixed-signal integrated circuits and sub-system solutions. The Company believes that the merger significantly furthers the Company's strategic goals of increasing revenue scale, diversifying revenues by end customers and addressable markets, and expanding its analog and mixed-signal footprint on existing tier-one customer platforms. Exar adds a diverse portfolio of high performance analog and mixed-signal products constituting power management and interface technologies that are ubiquitous functions in wireless and wireline communications infrastructure, broadband access, industrial, enterprise networking, and automotive platforms. The Company intends to leverage combined technological expertise, cross-selling opportunities and distribution channels to significantly expand its serviceable addressable market. The following table summarizes the fair value of purchase price consideration to acquire Exar (in thousands): Acquisition Consideration Amount Cash (1) $ 688,114 Fair value of vested stock-based awards assumed (2) 4,613 Total $ 692,727 __________________ (1) Cash consideration paid includes 51,953,635 shares ultimately tendered at $13.00 per share, or an aggregate total of $675.4 million , plus $12.7 million of cash paid to settle certain outstanding stock-based awards which were not assumed by MaxLinear in the merger. (2) MaxLinear assumed certain of Exar's outstanding stock-based awards as part of the merger, and estimated the fair value of such assumed stock-based awards. The portion allocated to purchase price consideration represents the vested assumed stock-based awards. The fair value of the MaxLinear equivalent stock options included in stock-based awards assumed was estimated using the Black-Scholes valuation model utilizing certain assumptions. Such assumptions are based on MaxLinear’s best estimates, which impact the fair value of the options calculated under the Black-Scholes methodology and, ultimately, the total consideration recorded for the acquisition. The following is an allocation of purchase price as of the May 12, 2017 closing date under the acquisition method of accounting. The purchase price allocation is based upon a preliminary estimate of the fair value of the assets acquired and the liabilities assumed by MaxLinear in the acquisition (in thousands): Description Amount Preliminary purchase price allocation: Cash $ 235,810 Accounts receivable 11,363 Inventory 48,536 Prepaid and other current assets 2,288 Property and equipment 3,442 Identifiable intangible assets 249,500 Deferred tax assets 7,675 Other assets 5,434 Accounts payable (12,385 ) Accrued expenses and other current liabilities (10,464 ) Accrued compensation (5,253 ) Other long-term liabilities (3,030 ) Identifiable net assets acquired 532,916 Goodwill 159,811 Total purchase price $ 692,727 The fair value of inventories acquired from Exar included an acquisition accounting fair market value step-up of $24.3 million , which was fully amortized in 2017. Included in other assets in the Exar purchase price allocation is $5.0 million held in escrow pertaining to indemnification obligations under the purchase agreement associated with the November 9, 2016 divestiture of a business unit by Exar (Note 13 ). The following table presents details of the identified intangible assets acquired of Exar: Estimated Useful Life (in years) Fair Value (in thousands) Developed technology 7.0 $ 120,900 Trademarks and tradenames 6.0 12,100 Customer-related intangible 5.0 96,300 Product backlog 0.5 3,600 Finite-lived intangible assets 6.0 232,900 In-process research and development N/A 16,600 Total intangible assets $ 249,500 Assumptions in the Allocation of Purchase Price Management prepared the purchase price allocation for Exar and, in doing so, considered or relied in part upon reports of a third party valuation expert to calculate the fair value of certain acquired assets, which primarily included identifiable intangible assets, inventory, and property and equipment. Estimates of fair value require management to make significant estimates and assumptions which are preliminary and subject to change upon finalization of the valuation analysis. The goodwill recognized is attributable primarily to the acquired workforce, expected synergies, and other benefits that MaxLinear believes will result from integrating the operations of Exar with the operations of MaxLinear. Certain liabilities and deferred taxes included in the purchase price allocations are based on management's best estimates of the amounts to be paid or settled and based on information available at the time the purchase price allocations were prepared. Adjustments between the preliminary purchase price allocations initially recorded as reflected in the Company's interim condensed consolidated financial statements as of June 30, 2017 and the amounts reflected as of March 31, 2018 have not been material. Updates to and/or completion of the estimates of certain tax-related assets acquired and liabilities assumed from Exar associated with the Company's evaluation of certain income tax positions of Exar may result in changes to the recorded amounts of assets and liabilities, with corresponding adjustments to goodwill amounts in subsequent reporting periods. We expect to complete the purchase price allocation for Exar within 12 months of the acquisition date. The fair value of the identified intangible assets acquired from Exar was estimated using an income approach. Under the income approach, an intangible asset's fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. Indications of value are developed by discounting future net cash flows to their present value at market-based rates of return. More specifically, the fair value of the developed technology, IPR&D and backlog assets was determined using the multi-period excess earnings method, or MPEEM. MPEEM is an income approach to fair value measurement attributable to a specific intangible asset being valued from the asset grouping’s overall cash-flow stream. MPEEM isolates the expected future discounted cash-flow stream to its net present value. Significant factors considered in the calculation of the developed technology and IPR&D intangible assets were the risks inherent in the development process, including the likelihood of achieving technological success and market acceptance. Each project was analyzed to determine the unique technological innovations, the existence and reliance on core technology, the existence of any alternative future use or current technological feasibility and the complexity, cost, and time to complete the remaining development. Future cash flows for each project were estimated based on forecasted revenue and costs, taking into account the expected product life cycles, market penetration, and growth rates. Developed technology will begin amortization immediately and IPR&D will begin amortization upon the completion of each project. If any of the projects are abandoned, the Company will be required to impair the related IPR&D asset. In connection with the acquisition of Exar, the Company has assumed liabilities related to product quality issues, warranty claims, and contract obligations, which are included in accrued expenses and other current liabilities in the purchase price allocation above. The Company has also assumed a purchase agreement that includes an indemnification obligation from Exar related to a November 9, 2016 business unit divestiture by Exar. Exar’s indemnification obligations for breaches of representations and warranties survived for 12 months from the closing of the divestiture, except for breaches of representations and warranties covering intellectual property, which survive for 18 months, and breaches of representations and warranties of certain fundamental representations, which survive until the expiration of the applicable statute of limitations. The amount of the indemnification for breaches of representations and warranties, covenants and other matters under the applicable purchase agreement could be up to the full purchase price received by Exar in the divestiture (Note 13 ). Goodwill recorded in connection with the acquisition of Exar was $159.8 million . The Company does not expect to deduct any of the acquired goodwill for tax purposes. Acquisition of Certain Assets and Assumption of Certain Liabilities of the G.hn business of Marvell Semiconductor, Inc. On April 4, 2017, the Company consummated the transactions contemplated by a share and asset acquisition agreement with Marvell Semiconductor, Inc., or Marvell, to purchase certain assets and assume certain liabilities of Marvell’s G.hn business, including its Spain legal entity, for aggregate cash consideration of $21.0 million . The Company also hired certain employees of the G.hn business outside of Spain and assumed employment obligations of the Spanish entity acquired, which is now a subsidiary of MaxLinear. The acquired assets and assumed liabilities, together with the employees who joined MaxLinear and its subsidiaries as a result of the transaction, represent a business as defined in ASC 805, Business Combinations . The Company has integrated the acquired assets and employees into its existing business. |
Restructuring Activity
Restructuring Activity | 3 Months Ended |
Mar. 31, 2018 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Activity | Restructuring Activity From time to time, the Company approves and implements restructuring plans as a result of acquisitions, internal resource alignment, and cost saving measures. Such restructuring plans include vacating certain leased facilities, terminating employees, and cancellation of contracts. In 2017, the Company incurred charges related to employee separation, incremental stock-based compensation, other severance-related, lease related and other charges resulting from the acquisition of Exar. There were no similar restructuring charges for the three months ended March 31, 2018 . Total sublease income related to leased facilities the Company ceased using was approximately $0.7 million for the three months ended March 31, 2018 . Sublease income was approximately $0.5 million for the three months ended March 31, 2017 . The following table presents a roll-forward of the Company's restructuring liability for the three months ended March 31, 2018 . The restructuring liability is included in accrued expenses and other current liabilities in the consolidated balance sheets. Employee Separation Expenses Lease Related Charges Other Total (in thousands) Liability as of December 31, 2017 $ 239 $ 2,693 $ 107 $ 3,039 Cash payments (172 ) (570 ) — (742 ) Non-cash items (25 ) (27 ) (70 ) (122 ) Liability as of March 31, 2018 $ 42 $ 2,096 $ 37 $ 2,175 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 3 Months Ended |
Mar. 31, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company's estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date). During the three months ended March 31, 2018 , the Company adjusted its allocation of purchase price for the acquisition of Exar related to updates to estimates of certain tax-related assets acquired and liabilities assumed with a corresponding decrease in goodwill of $0.2 million . The following table presents the changes in the carrying amount of goodwill: Carrying Amount (in thousands) Balance as of December 31, 2017 $ 237,992 Adjustments (182 ) Balance as of March 31, 2018 $ 237,810 The Company performs an annual goodwill impairment assessment on October 31st each year, using a two-step quantitative assessment. Step one is the identification of potential impairment. This involves comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds the carrying amount, the goodwill of the reporting unit is considered not impaired and the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the impairment test is performed to measure the amount of impairment loss, if any. In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the three months ended March 31, 2018 and 2017 , no indications of impairment of the Company's goodwill balances were identified and, as a result, no goodwill impairment was recognized. Acquired Intangibles Finite-lived Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: March 31, 2018 December 31, 2017 Weighted Average Useful Life (in Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Licensed technology 3.7 $ 2,070 $ (718 ) $ 1,352 $ 2,070 $ (575 ) $ 1,495 Developed technology 6.9 241,561 (48,220 ) 193,341 241,561 (39,252 ) 202,309 Trademarks and trade names 6.1 13,800 (2,557 ) 11,243 13,800 (1,992 ) 11,808 Customer relationships 4.6 121,100 (33,908 ) 87,192 121,100 (26,661 ) 94,439 Non-compete covenants 3.0 1,100 (597 ) 503 1,100 (506 ) 594 6.1 $ 379,631 $ (86,000 ) $ 293,631 $ 379,631 $ (68,986 ) $ 310,645 The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of income as follows: Three Months Ended March 31, 2018 2017 (in thousands) Cost of net revenue $ 8,978 $ 2,684 Research and development 42 137 Selling, general and administrative 7,994 1,881 $ 17,014 $ 4,702 Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of income results primarily from acquired developed technology. The following table sets forth the activity during the three months ended March 31, 2018 related to finite-lived intangible assets resulting from amortization: Carrying Amount (in thousands) Balance as of December 31, 2017 $ 310,645 Amortization (17,014 ) Balance as of March 31, 2018 $ 293,631 The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During the three months ended March 31, 2018 and 2017 , no impairment losses related to finite-lived intangible assets were recognized. The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2018 : Amount (in thousands) 2018 (9 months) $ 51,027 2019 57,191 2020 56,325 2021 55,542 2022 38,012 Thereafter 35,534 Total $ 293,631 Indefinite-lived Intangible Assets There were no changes in the Company’s indefinite-lived intangible assets during the three months ended March 31, 2018. The Company performs its annual assessment of indefinite-lived intangible assets on October 31 each year or more frequently if events or changes in circumstances indicate that the asset might be impaired utilizing a qualitative test as a precursor to the quantitative test comparing the fair value of the assets with their carrying amount. Based on the qualitative test, if it is more likely than not that indicators of impairment exists, the Company proceeds to perform a quantitative analysis. During the three months ended March 31, 2018 and 2017, no indicators of impairment were identified and, as a result, no impairment of indefinite-lived intangible assets was recorded. |
Financial Instruments
Financial Instruments | 3 Months Ended |
Mar. 31, 2018 | |
Fair Value Disclosures [Abstract] | |
Financial Instruments | Financial Instruments The composition of financial instruments is as follows: March 31, 2018 December 31, 2017 (in thousands) Assets Interest rate swap $ 2,118 $ 734 The fair value of the Company’s financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. Level 3: Unobservable inputs are used when little or no market data is available. The Company classifies its financial instrument within Level 2 of the fair value hierarchy on the basis of models utilizing market observable inputs. The interest rate swap has been valued on the basis of valuations provided by third-party pricing services, as derived from standard valuation or pricing models. The pricing services may use market-based observable inputs for the interest rate swap over the term of the swap, including one month LIBOR-based yield curves and have been classified as Level 2. The Company reviews Level 2 inputs and fair value for reasonableness and the values may be further validated by comparison to independent pricing sources. In addition, the Company reviews third-party pricing provider models, key inputs and assumptions and understands the pricing processes at its third-party providers in determining the overall reasonableness of the fair value of its Level 2 financial instruments. The Company also considers the risk of nonperformance by assessing the swap counterparty's credit risk in the estimate of fair value of the interest rate swap. As of March 31, 2018 and December 31, 2017 , the Company has not made any adjustments to the valuations obtained from its third-party pricing providers. The following table presents a summary of the Company’s financial instruments that were measured at fair value on a recurring basis and the related level of the fair value hierarchy: Fair Value Measurements Balance Quoted Prices Significant Significant (in thousands) Interest rate swap, March 31, 2018 $ 2,118 $ — $ 2,118 $ — Interest rate swap, December 31, 2017 $ 734 $ — $ 734 $ — The following table summarizes activity for the interest rate swap: Three Months Ended March 31, March 31, (in thousands) Interest rate swap asset Beginning balance $ 734 $ — Unrealized gain included in other comprehensive income 1,384 — Ending balance $ 2,118 $ — There were no transfers between Level 1, Level 2 or Level 3 financial instruments in the three months ended March 31, 2018 and 2017 . Financial Instruments Not Recorded at Fair Value on a Recurring Basis Some of the Company’s financial instruments are not measured at fair value on a recurring basis but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities. The Company’s long-term debt is not recorded at fair value on a recurring basis, but is measured at fair value for disclosure purposes (Note 8 ). |
Balance Sheet Details
Balance Sheet Details | 3 Months Ended |
Mar. 31, 2018 | |
Balance Sheet Related Disclosures [Abstract] | |
Balance Sheet Details | Balance Sheet Details Cash, cash equivalents and restricted cash consist of the following: March 31, 2018 December 31, 2017 (in thousands) Cash and cash equivalents $ 55,645 $ 71,872 Short-term restricted cash 617 1,476 Long-term restricted cash 1,071 1,064 Total cash, cash equivalents and restricted cash $ 57,333 $ 74,412 Inventory consists of the following: March 31, 2018 December 31, 2017 (in thousands) Work-in-process $ 21,102 $ 21,823 Finished goods 24,518 31,611 Inventory expected to be received from distributors as returns 138 — $ 45,758 $ 53,434 Property and equipment, net consists of the following: Useful Life March 31, 2018 December 31, 2017 (in thousands) Furniture and fixtures 5 $ 2,103 $ 2,105 Machinery and equipment 3-5 34,221 33,462 Masks and production equipment 2 11,788 11,470 Software 3 4,704 4,695 Leasehold improvements 1-5 14,271 14,340 Construction in progress N/A 1,980 639 69,067 66,711 Less accumulated depreciation and amortization (47,074 ) (44,053 ) $ 21,993 $ 22,658 Depreciation expense for the three months ended March 31, 2018 and 2017 was $3.1 million and $2.2 million , respectively. Deferred revenue and deferred profit consist of the following: March 31, 2018 December 31, 2017 (1) (in thousands) Deferred revenue—rebates $ — $ 156 Deferred revenue—distributor transactions — 5,341 Deferred cost of net revenue—distributor transactions — (1,135 ) $ — $ 4,362 __________ (1) Due to the adoption of ASC 606 using the modified retrospective method, prior period amounts have not been adjusted to reflect the change to recognize certain distributor sales upon sale to the distributor, or the sell-in method, from recognition upon the Company's sale to the distributors' end customers, or the sell-through method, which required the deferral of revenue and profit on such distributor sales. Accrued price protection liability consists of the following activity: Three Months Ended March 31, 2018 2017 (in thousands) Beginning balance $ 21,571 $ 15,176 Charged as a reduction of revenue 10,744 11,698 Reversal of unclaimed rebates (2,367 ) — Payments (9,736 ) (4,927 ) Ending balance $ 20,212 $ 21,947 Accrued expenses and other current liabilities consist of the following: March 31, 2018 December 31, 2017 (1) (in thousands) Accrued technology license payments $ 4,500 $ 4,500 Accrued professional fees 857 1,497 Accrued engineering and production costs 618 2,378 Accrued restructuring 2,175 3,039 Accrued royalty 1,027 1,206 Accrued leases—other 1,129 1,105 Accrued customer credits 1,315 2,667 Customer contract liabilities 114 — Accrued obligations to customers for price adjustments 10,729 — Accrued obligations to customers for stock rotation rights 1,077 — Other 2,172 3,914 $ 25,713 $ 20,306 ___________ (1) Due to the adoption of ASC 606 using the modified retrospective method, prior period amounts have not been adjusted to include customer contract liabilities and accrued obligations to customers for price adjustments and stock rotation rights, which are now required to be estimated and disclosed at the time of sale. |
Debt
Debt | 3 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Debt | Debt and Interest Rate Swap Debt The carrying amount of the Company's long-term debt consists of the following: March 31, December 31, (in thousands) Principal $ 330,000 $ 355,000 Less: Unamortized debt discount (1,855 ) (1,930 ) Unamortized debt issuance costs (5,249 ) (5,461 ) Net carrying amount of long-term debt 322,896 347,609 Less: current portion of long-term debt — — Long-term debt, non-current portion $ 322,896 $ 347,609 On May 12, 2017, the Company entered into a credit agreement with certain lenders and a collateral agent in connection with the acquisition of Exar (Note 3 ). The credit agreement provides for an initial secured term B loan facility, or the “Initial Term Loan,” in an aggregate principal amount of $425.0 million . The credit agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of $160.0 million (subject to adjustments for any voluntary prepayments), plus an unlimited amount that is subject to pro forma compliance with certain secured leverage ratio and total leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the credit agreement or new lenders. Loans under the credit agreement bear interest, at the Company’s option, at a rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50% , (y) the prime rate then in effect and (z) an adjusted LIBOR rate determined on the basis of a one- three- or six-month interest period, plus 1.0% or (ii) an adjusted LIBOR rate, subject to a floor of 0.75% , in each case, plus an applicable margin of 2.50% in the case of LIBOR rate loans and 1.50% in the case of base rate loans. Commencing on September 30, 2017, the Initial Term Loan will amortize in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan, with the balance payable on the maturity date. The Initial Term Loan has a term of seven years and will mature on May 12, 2024, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan must be repaid. The Company is also required to pay fees customary for a credit facility of this size and type. The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the credit agreement with the net cash proceeds from the disposition of certain assets and the receipt of insurance proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the credit agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months of the loan term. The Company exercised its right to prepay and made aggregate prepayments of principal of $95.0 million from origination through March 31, 2018 . The Company’s obligations under the credit agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the credit agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a security agreement with the collateral agent. The credit agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions. As of March 31, 2018 , the Company was in compliance with such covenants. The credit agreement also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the credit agreement, and may exercise certain other rights and remedies provided for under the credit agreement, the other loan documents and applicable law. As of March 31, 2018 , the weighted average effective interest rate payable on the long-term debt was 4.3% . The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $398.5 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 4.6% , which represents a Level 3 fair value measurement. The debt discount of $2.1 million and debt issuance costs of $6.0 million are being amortized to interest expense using the effective interest method from the issuance date through the contractual maturity date of the term loan of May 12, 2024. During the three months ended March 31, 2018 , the Company recognized total amortization of debt discount and debt issuance costs of $0.3 million to interest expense. The approximate fair value of the term loan as of March 31, 2018 was $320.8 million , which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy. As of March 31, 2018 , the remaining principal balance on the term loan of $330.0 million is due on May 12, 2024 at the maturity date on the term loan. Interest Rate Swap In November 2017, the Company entered into a fixed-for-floating interest rate swap with an amortizing notional amount to swap a substantial portion of variable rate LIBOR interest payments under its term loans for fixed interest payments bearing an interest rate of 1.74685% . The Company's outstanding debt is still subject to a 2.5% fixed applicable margin during the term of the loan. The interest rate swap is designated as a cash flow hedge of a portion of floating rate interest payments on long-term debt and effectively fixes the interest rate on a substantial portion of the Company’s long-term debt at approximately 4.25% . Accordingly, the Company applies cash flow hedge accounting to the interest rate swap and it is recorded at fair value as an asset or liability and the effective portion of changes in the fair value of the interest rate swap, as measured quarterly, are reported in other comprehensive income (loss). As of March 31, 2018 and December 31, 2017 , the fair value of the interest rate swap asset was $2.1 million and $0.7 million (Note 6 ), respectively, and is included in other long-term assets in the consolidated balance sheets. The increase in fair value related to the interest rate swap asset included in other comprehensive income for the three months ended March 31, 2018 was $1.4 million . The interest rate swap expires in October 2020 and the total $1.4 million of unrealized gain recorded in accumulated other comprehensive income at March 31, 2018 is not expected to be recorded against interest expense over the next twelve months. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation and Employee Benefit Plans | Stock-Based Compensation and Employee Benefit Plans Employee Stock-Based Benefit Plans At March 31, 2018 , the Company had stock-based compensation awards outstanding under the following plans: the 2004 Stock Plan, the 2010 Equity Incentive Plan, as amended, or 2010 Plan, the 2010 Employee Stock Purchase Plan, or ESPP, and plans under which equity incentive awards were assumed in connection with the acquisitions of Entropic in 2015 and Exar Corporation in 2017. Refer to the Company’s Annual Report for a summary of the Company's stock-based compensation and equity plans as of December 31, 2017 . There have been no material changes to the terms of the Company's equity incentive plans during the three months ended March 31, 2018 . All current stock awards are issued under the 2010 Plan and ESPP. As of March 31, 2018 , the number of shares of common stock reserved for issuance under the 2010 Plan was 13,874,903 shares. As of March 31, 2018 , the number of shares of common stock reserved for issuance under the ESPP was 2,406,646 shares. Stock-Based Compensation The Company recognizes stock-based compensation in the consolidated statements of income, based on the department to which the related employee reports, as follows: Three Months Ended March 31, 2018 2017 (in thousands) Cost of net revenue $ 106 $ 59 Research and development 4,374 3,493 Selling, general and administrative 3,993 1,922 $ 8,473 $ 5,474 The total unrecognized compensation cost related to unvested restricted stock units and restricted stock awards as of March 31, 2018 was $47.7 million , and the weighted average period over which these equity awards are expected to vest is 2.33 years. The total unrecognized compensation cost related to unvested stock options as of March 31, 2018 was $5.5 million , and the weighted average period over which these equity awards are expected to vest is 1.75 years. Restricted Stock Units and Restricted Stock Awards The Company calculates the fair value of restricted stock units based on the fair market value of the Company's common stock on the grant date. Stock based compensation is recognized over the vesting period using the straight-line method. A summary of the Company’s restricted stock unit and restricted stock award activity is as follows: Number of Shares (in thousands) Weighted-Average Grant-Date Fair Value per Share Outstanding at December 31, 2017 3,183 $ 20.13 Granted 397 23.42 Vested (663 ) 19.97 Canceled (58 ) 22.36 Outstanding at March 31, 2018 2,859 20.61 Employee Stock Purchase Rights and Stock Options The Company uses the Black-Scholes valuation model to calculate the fair value of employee stock purchase rights and stock options granted to employees. Stock based compensation expense is recognized over the vesting period using the straight-line method. Employee Stock Purchase Rights During the three months ended March 31, 2018 , there were no shares of common stock purchased under the ESPP. The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions: Three Months Ended March 31, 2018 Weighted-average grant date fair value per share $ 6.51 Risk-free interest rate 1.39 % Dividend yield — % Expected life (in years) 0.50 Volatility 36.97 % The risk-free interest rate assumption was based on the United States Treasury’s rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company's daily closing stock prices. Stock Options A summary of the Company’s stock options activity is as follows: Number of Options (in thousands) Weighted-Average Exercise Price Weighted-Average Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at December 31, 2017 3,069 $ 8.95 Exercised (129 ) 7.63 Canceled (5 ) 18.40 Outstanding at March 31, 2018 2,935 $ 8.99 2.36 $ 40,641 Vested and expected to vest at March 31, 2018 2,899 $ 8.90 2.33 $ 40,413 Exercisable at March 31, 2018 2,559 $ 8.07 2.03 $ 37,767 No stock options were granted by the Company during the three months ended March 31, 2018 . The intrinsic value of stock options exercised was $2.1 million and $1.9 million in the three months ended March 31, 2018 and 2017 , respectively. Cash received from exercise of stock options was $1.0 million and $0.4 million during the three months ended March 31, 2018 and 2017 , respectively. The tax benefit from stock options exercised was $2.1 million and $0.3 million during the three months ended March 31, 2018 and 2017 , respectively. Employee Incentive Bonus The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the 2010 Equity Incentive Plan. When bonus awards are settled in common stock issued under the 2010 Equity Incentive Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company's common stock as determined in trading on the New York Stock Exchange on a date approved by the Board of Directors. In connection with the Company's bonus programs, in February 2018, the Company issued 0.3 million freely-tradable shares of the Company's common stock in settlement of bonus awards to employees, including executives, for the 2017 performance period. At March 31, 2018 , the Company has an accrual of $1.8 million for bonus awards for employees for year-to-date achievement in the 2018 performance period. The Company's compensation committee retains discretion to effect payment in cash, stock, or a combination of cash and stock. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2018 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The provision for income taxes primarily related to projected current federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company used an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual item are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company's review of all positive and negative evidence, the Company released the valuation allowance against certain of its federal deferred tax assets during the three months ended June 30, 2017. The Company continues to have a valuation allowance on its state deferred taxes, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax free jurisdictions in which it operates. The Company recorded an income tax benefit of $1.9 million in the three months ended March 31, 2018 and a provision for income taxes of $2.0 million for the three months ended March 31, 2017 . The income tax benefit in the three months ended March 31, 2018 primarily relates to the mix of pre-tax income among jurisdictions, excess tax benefits related to stock-based compensation, and release of certain foreign reserves for uncertain tax positions under ASC 740-10. The provision for income taxes in the three months ended March 31, 2017 primarily relates to federal alternative minimum tax due to the Company's limitation on use of net operating losses, credit carryforwards, state income taxes, and income taxes in certain foreign jurisdictions. Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of income as income tax expense. During the three months ended March 31, 2018 , the Company’s unrecognized tax benefits decreased by $0.7 million . The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of March 31, 2018 were approximately $0.8 million and $0.2 million , respectively. The Company is subject to federal and state income tax in the United States and is also subject to income tax in various states and foreign tax jurisdictions. At March 31, 2018 , the Company’s tax years for 2013 , 2012 , and 2009 and forward are subject to examination by federal, state, and foreign tax authorities, respectively. The Company is currently under examination by the California Franchise Tax Board for the 2014 and 2015 tax years. The Company does not expect the examination to have a material effect on the Company's consolidated financial position or results of operations. However, certain of the Company's state tax attribute carryforwards, which currently have a full valuation allowance, could be reduced. In April 2017, the Company's subsidiary in Singapore began operating under certain tax incentives in Singapore, which are generally effective through March 2022, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company's integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. Primarily because of the Company's Singapore net operating losses and a full valuation allowance in Singapore, the incentives did not have a material impact on the Company's income tax benefit in the three months ended March 31, 2018 . On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act, or the Tax Act. Changes include, but are not limited to, a corporate tax rate decrease from 35% to 21% effective for tax years beginning in 2018, the transition of U.S international taxation from a worldwide tax system to a territorial system, which includes a new federal tax on global intangible low-taxed income (Global Minimum Tax or GMT), and a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings as of December 31, 2017. In its 2017 consolidated financial statements, the Company calculated its best estimate of the impact of the Tax Act in its 2017 income tax benefit in accordance with its understanding of the Tax Act and guidance available as of the date of the filing of the Annual Report. In addition, the SEC Staff issued SAB 118, which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. If a company cannot determine a provisional estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provisions of the tax laws that were in effect immediately before the enactment of the Tax Act. The Company was able to make reasonable estimates of certain effects and, therefore, recorded certain provisional adjustments in the 2017 income tax benefit. Refer to Note 10 to the Company's consolidated financial statements included in the Annual Report for further details. During the three month period ended March 31, 2018, the Company recognized no adjustments to the provisional amounts recorded at December 31, 2017. Additionally, the Company has provided provisional amounts for the legislative provisions that are effective as of January 1, 2018, including, but not limited to, the creation of the base erosion anti-abuse tax (BEAT), a new global minimum tax, GMT, a new limitation on deductible interest expense, and limitations on the use of net operating losses. At March 31, 2018, the Company's accounting for certain elements of the Tax Act is incomplete. The provisional amounts recorded are subject to revisions as the Company completes its analysis of the Tax Act, collects and prepares necessary data, and interprets any additional guidance issued by the U.S. Treasury Department, Internal Revenue Service, or IRS, FASB, and other standard-setting and regulatory bodies. Adjustments to the provisional amounts may materially impact the Company's consolidated income tax provision (benefit) and effective tax rates in the period(s) in which such adjustments are made. In all cases, the Company will continue to make and refine calculations as additional analysis is completed. The Company's accounting for the tax effects of the Tax Act will be completed during the one-year measurement period. Under U.S. GAAP, the Company is allowed to make an accounting policy choice with respect to the GMT of either (1) treating taxes due on future U.S. inclusions in taxable income related to GMT as a current-period expense when incurred or (2) as a component of deferred income taxes. The Company will make its accounting policy election for this item when its analysis is complete, during the measurement period. At March 31, 2018, because the Company is still evaluating the GMT provisions and an analysis of future taxable income that is subject to GMT, the Company has included GMT related to current year operations only in the estimated annual effective tax rate and has not provided additional GMT on deferred items. |
Concentration of Credit Risk, S
Concentration of Credit Risk, Significant Customers and Geographic Information | 3 Months Ended |
Mar. 31, 2018 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risk, Significant Customers and Geographic Information | Concentration of Credit Risk, Significant Customers and Revenue by Geographic Region Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents. Significant Customers The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company makes periodic evaluations of the credit worthiness of its customers. Customers comprising greater than 10% of net revenues for each of the periods presented are as follows: Three Months Ended March 31, 2018 2017 Percentage of total net revenue Customer A 27 % 31 % Balances that are 10% or greater of accounts receivable, based on the Company's billings to the contract manufacturer customers, are as follows: March 31, December 31, 2018 2017 Percentage of gross accounts receivable Customer A 10 % * Customer B 13 % 17 % Customer C * 10 % ____________________________ * Represents less than 10% of the gross accounts receivable as of the respective period end. Suppliers comprising greater than 10% of total inventory purchases are as follows: Three Months Ended March 31, 2018 2017 Vendor A 21 % 21 % Vendor B 19 % 19 % Vendor C * 15 % Vendor D 16 % 12 % Vendor E 14 % 17 % ____________________________ * Represents less than 10% of the inventory purchases for the respective period. Geographic Information The Company's consolidated net revenues by geographic area based on ship-to location are as follows: Three Months Ended March 31, 2018 2017 Amount % of total net revenue Amount % of total net revenue Asia $ 84,814 77 % $ 84,332 95 % United States 5,195 5 % 145 — % Rest of world 20,818 19 % 4,364 5 % Total $ 110,827 100 % $ 88,841 100 % The products shipped to individual countries representing greater than 10% of net revenue for each of the periods presented are as follows: Three Months Ended March 31, 2018 2017 Percentage of total net revenue China 61 % 78 % The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country in Asia Pacific, United States, or the rest of the world accounted for more than 10% of net revenue during these periods. Long-lived assets, which consists of property and equipment, net, intangible assets, net, and goodwill by geographic area are as follows (in thousands): March 31, December 31, 2018 2017 Amount % of total Amount % of total United States $ 468,774 84 % $ 481,638 84 % Singapore 87,187 16 % 92,414 16 % Rest of world 2,055 — % 1,643 — % Total $ 558,016 100 % $ 575,695 100 % |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Lease Commitments and Other Contractual Obligations The Company leases facilities and certain equipment under operating lease arrangements expiring at various years through 2023 . As of March 31, 2018 , future minimum payments under non-cancelable operating leases, inventory purchase and other obligations are as follows: Operating Leases Inventory Purchase Obligations Other Obligations Total (in thousands) 2018 (9 months) $ 6,631 $ 49,183 $ 5,651 $ 61,465 2019 9,242 — 7,761 17,003 2020 9,444 — 3,781 13,225 2021 9,238 — 30 9,268 2022 5,102 — — 5,102 Thereafter 792 — — 792 Total minimum payments $ 40,449 $ 49,183 $ 17,223 $ 106,855 Other obligations consist of contractual payments due for software licenses. The total rental expense for operating leases was $1.2 million and $0.7 million for the three months ended March 31, 2018 and 2017 , respectively. The Company has subleased certain facilities that it ceased using in connection with prior years' restructuring plans (Note 4 ). Such subleases expire at various years through fiscal 2023 . As of March 31, 2018 , future minimum rental income under non-cancelable subleases is as follows: Amount (in thousands) 2018 (9 months) $ 2,184 2019 3,604 2020 4,088 2021 4,152 2022 879 Thereafter 352 Total minimum rental income $ 15,259 Total sublease income related to leased facilities the Company ceased using in connection with a restructuring plan for the three months ended March 31, 2018 and 2017 was approximately $0.7 million and $0.5 million , respectively (Note 4 ). Exar iML Divestiture Indemnification Under the terms of the purchase agreement relating to the November 9, 2016 divestiture of Integrated Memory Logic Limited, or iML, by Exar, Exar agreed to indemnify the purchaser of the business unit for breaches of representations and warranties and covenants and for certain other matters. Exar also agreed to place $5.0 million of the total purchase price into an escrow account for a period of 18 months to partially secure its indemnification obligations under the purchase agreement; of this amount, $0.9 million has been released through March 31, 2018 . In addition, Exar’s indemnification obligations for breaches of representations and warranties survived for 12 months from the closing of the sale transaction, except for breaches of representations and warranties covering intellectual property, which survive for 18 months, and breaches of representations and warranties of certain fundamental representations, which survive until the expiration of the applicable statute of limitations. Exar’s maximum indemnification obligation for breaches of representations and warranties, other than intellectual property and fundamental representations, is $13.6 million , its maximum indemnification obligation for breaches of intellectual property representations is $34.0 million , and is maximum indemnity obligation for breaches of fundamental representations is the full purchase price amount (approximately $136.0 million ). The aggregate amount recovered by the purchaser in accordance with the indemnification provisions with respect to matters that are subject to the intellectual property representations, together with the aggregate amount recovered by the Buyer in accordance with the indemnification provisions with respect to matters that are subject to the general representations and warranties (other than fundamental representations), will in no event exceed $34.0 million . If the Company were required to make payments in satisfaction of these indemnification obligations, it could have a material adverse effect on the Company's business, financial condition, results of operations, and cash flows. CrestaTech Litigation On January 21, 2014, CrestaTech Technology Corporation, or CrestaTech, filed a complaint for patent infringement against the Company in the United States District Court of Delaware, or the District Court Litigation. In its complaint, CrestaTech alleged that the Company infringed U.S. Patent Nos. 7,075,585, or the ‘585 Patent and 7,265,792, or the ‘792 Patent. In addition to asking for compensatory damages, CrestaTech alleged willful infringement and sought a permanent injunction. CrestaTech also named Sharp Corporation, Sharp Electronics Corp. and VIZIO, Inc. as defendants based upon their alleged use of the Company's television tuners. On January 28, 2014, CrestaTech filed a complaint with the U.S. International Trade Commission, or ITC, again naming, among others, MaxLinear, Sharp, Sharp Electronics, and VIZIO, or the ITC Investigation. On May 16, 2014, the ITC granted CrestaTech’s motion to file an amended complaint adding six OEM Respondents, namely, SIO International, Inc., Hon Hai Precision Industry Co., Ltd., Wistron Corp., Wistron Infocomm Technology (America) Corp., Top Victory Investments Ltd. and TPV International (USA), Inc. which are collectively referred to with MaxLinear, Sharp and VIZIO as the Company Respondents. CrestaTech’s ITC complaint alleged a violation of 19 U.S.C. § 1337 through the importation into the United States, the sale for importation, or the sale within the United States after importation of MaxLinear's accused products that CrestaTech alleged infringe the same two patents asserted in the Delaware action. Through its ITC complaint, CrestaTech sought an exclusion order preventing entry into the United States of certain of the Company's television tuners and televisions containing such tuners from Sharp, Sharp Electronics, and VIZIO. CrestaTech also sought a cease and desist order prohibiting the Company Respondents from engaging in the importation into, sale for importation into, the sale after importation of, or otherwise transferring within the United States certain of the Company's television tuners or televisions containing such tuners. On March 10, 2014, the court stayed the District Court Litigation pending resolution of the ITC Investigation. On December 15, 2014, the ITC held a trial in the ITC Investigation. On February 27, 2015, the Administrative Law Judge, or the ALJ, issued a written Initial Determination, or ID, ruling that the Company Respondents do not violate Section 1337 in connection with CrestaTech’s asserted patents because CrestaTech failed to satisfy the economic prong of the domestic industry requirement pursuant to Section 1337(a)(2). In addition, the ID stated that certain of the Company's television tuners and televisions incorporating those tuners manufactured and sold by certain customers infringe three claims of the ‘585 Patent (claims 10, 12 and 13), and these three claims were not determined to be invalid. On April 30, 2015, the ITC issued a notice indicating that it intended to review portions of the ID finding no violation of Section 1337, including the ID’s findings of infringement with respect to, and validity of, the ‘585 Patent, and the ID’s finding that CrestaTech failed to establish the existence of a domestic industry within the meaning of Section 1337. The ITC subsequently issued its opinion, which terminated its investigation. The opinion affirmed the findings of the ALJ that no violation of Section 1337 had occurred because CrestaTech had failed to establish the economic prong of the domestic industry requirement. The ITC also affirmed the ALJ's finding of infringement with respect to the three claims of the '585 Patent that were not held to be invalid. On November 30, 2015, CrestaTech filed an appeal of the ITC decision with the United States Court of Appeals for the Federal Circuit, or the Federal Circuit. On March 7, 2016, CrestaTech voluntarily dismissed its appeal, resulting in a final determination of the ITC Investigation in the Company's favor. In addition, the Company has filed four petitions for inter partes review, or IPR, by the US Patent Office, two for each of the CrestaTech patents asserted against the Company. The Patent Trial and Appeal Board, or the PTAB, did not institute two of these IPRs as being redundant to IPRs filed by another party that were already underway for the same CrestaTech patent. The remaining two petitions were instituted or instituted-in-part meaning, together with the IPRs filed by third parties, there were currently six IPR proceedings instituted involving the two CrestaTech patents asserted against the Company. In October 2015, the PTAB issued final decisions in two of the six pending IPR proceedings (one for each of the two asserted patents), holding that all of the reviewed claims are unpatentable. Included in these decisions was one of the three claims of the ‘585 Patent (claim 10) mentioned above in connection with the ITC’s final decision. CrestaTech appealed the PTAB’s decisions at the Federal Circuit. On November 8, 2016, the Federal Circuit issued an opinion affirming the PTAB’s finding of unpatentability. In August 2016, the PTAB issued final written decisions in the remaining four pending IPR proceedings (two for each of the asserted patents), holding that many of the reviewed claims - including the two remaining claims of the ‘585 Patent which the ITC held were infringed - are unpatentable. The parties have appealed the two decisions related to the ‘585 Patent; however, no appeals were filed as to the PTAB's rulings for the ‘792 Patent. The Federal Circuit heard oral argument on these appeals on December 4, 2017. On December 7, the Federal Circuit issued a Rule 36 affirmance in one of the '585 appeals, affirming that the two remaining claims that the ITC had ruled were valid and infringed (claims 12 and 13) are unpatentable. On January 25, 2018, the Federal Circuit issued its ruling in the other ‘585 appeal, vacating the PTAB's ruling that certain claims were not unpatentable and remanding to the PTAB for further analysis of whether CrestaTech is estopped from arguing and/or has waived the right to argue whether six dependent claims are patentable. As a result of these IPR decisions, all 13 claims that CrestaTech asserted against the Company in the ITC Investigation have been found to be unpatentable by the PTAB and the Federal Circuit. On March 18, 2016, CrestaTech filed a petition for Chapter 7 bankruptcy in the Northern District of California. As a result of this proceeding, all rights in the CrestaTech asserted patents, including the right to control the pending litigation, were assigned to CF Crespe LLC, or CF Crespe. CF Crespe became the named party in the then-pending IPRs, Federal Circuit appeal and District Court Litigation. In April 2017, the Delaware court continued the stay of the District Court Litigation per the parties’ request, pending resolution of the Federal Circuit appeals in the IPR’s. The parties are in the process of submitting an updated status report, in which at least we will request that the stay continue pending resolution of the one remaining IPR proceeding. The Company cannot predict the outcome of the District Court Litigation, or the IPRs. Any adverse determination in the District Court Litigation could have a material adverse effect on the Company's business, financial condition, results of operations and cash flows. Trango Systems, Inc. Litigation On or about August 2, 2016, Trango Systems, Inc., or Trango, filed a complaint in the Superior Court of California, County of San Diego, Central Division, against defendants Broadcom Corporation, Inc., or Broadcom, and the Company, collectively, Defendants. Trango is a purchaser that alleges various fraud, breach of contract, and interference with economic relations claims in connection with the discontinuance of a chip line the Company acquired from Broadcom in 2016. Trango seeks unspecified general and special damages, pre-judgment interest, expenses and costs, attorneys’ fees, punitive damages, and unspecified injunctive and equitable relief. On June 23, 2017, the Court sustained the Company's demurrer to each cause of action in the second amended complaint filed on or about December 6, 2016. Trango filed its third amended complaint on or about July 13, 2017. On February 23, 2018, the Court sustained, in part, MaxLinear’s demurrer, dismissing with prejudice the cause of action for breach of a written contract, and Trango voluntarily dismissed its cause of action for breach of an implied-in-fact contract. The remaining causes of action have been permitted to proceed. On March 15, 2018, Trango filed its fourth amended complaint. MaxLinear filed its answer on April 17, 2018. Also, on April 17, Broadcom filed a cross-complaint against the Company, alleging causes of action for indemnity, contribution and apportionment, and declaratory relief. The cross-complaint seeks damages from MaxLinear to reimburse Broadcom for the fees and costs it is incurring for the lawsuit, along with attorneys’ fees and costs. On May 2, 2018, Broadcom filed a request to voluntarily dismiss its cross-complaint. As of now, no trial date has been set. The Court set a case management conference set for June 1, 2018. The Company intends to vigorously defend against the lawsuit as it proceeds. The Company cannot predict the outcome of the Trango Systems, Inc. litigation. Any adverse determination in the Trango Systems, Inc. litigation could have a material adverse effect on the Company's business, financial condition, results of operations and cash flows. Other Matters In addition, from time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business, some of which may be material. Other than the CrestaTech and Trango litigation described above, the Company believes that there are no other currently pending litigation matters that, if determined adversely by the Company, would have a material effect on the Company's business or that would not be covered by the Company's existing liability insurance. |
Revenue from Contracts with Cus
Revenue from Contracts with Customers (Notes) | 3 Months Ended |
Mar. 31, 2018 | |
Revenue from Contracts with Customers [Abstract] | |
Revenue Recognition, Sales of Goods [Policy Text Block] | Revenue from Contracts with Customers Revenue by Market The table below presents disaggregated net revenues by market (in thousands): Three months ended March 31, 2018 2017 (1) Connected home $ 65,658 $ 77,240 % of net revenue 59 % 87 % Infrastructure 20,490 11,534 % of net revenue 19 % 13 % Industrial and multi-market 24,679 67 % of net revenue 22 % — % Total net revenue $ 110,827 $ 88,841 ___________ (1) Due to the adoption of ASC 606 using the modified retrospective method, prior period amounts have not been adjusted to reflect the change to recognize certain distributor sales upon sale to the distributor, or the sell-in method, from recognition upon the Company's sale to the distributors' end customers, or the sell-through method, which required the deferral of revenue and profit on such distributor sales. Contract Liabilities As of March 31, 2018 , customer contract liabilities consist of estimates of obligations to deliver rebates to customers in the form of units of products and were approximately $0.1 million . Revenue recognized in the three months ended March 31, 2018 that was included in the contract liability balance as of January 1, 2018 was immaterial. There were no material changes in the contract liabilities balance during the three months ended March 31, 2018 . Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns As of March 31, 2018 , obligations to customers consisting of estimates of price protection rights offered to the Company's end customers totaled $20.2 million and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7 . Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold were $10.7 million and $1.1 million , respectively, and are included in accrued expenses and other liabilities in the consolidated balance sheets (Note 7 ). The increase in revenue from net changes in transaction prices for amounts included in obligations to customers for price adjustments as of January 1, 2018 was not material. As of March 31, 2018 , right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $0.1 million . Right of return assets are included in inventory in the consolidated balance sheets (Note 7 ). As of March 31, 2018 , there were no impairment losses recorded on customer accounts receivable. |
Organization and Summary of S21
Organization and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its wholly owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of radio-frequency, or RF, high-performance analog, and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear's customers include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices, including cable DOCSIS broadband modems and gateways, wireline connectivity devices for in-home networking applications, RF transceivers and modems for wireless carrier access and backhaul infrastructure, fiber-optic modules for data center, metro, and long-haul transport networks, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products used in these and a range of other markets. The Company is a fabless integrated circuit design company whose products integrate all or a substantial portions of a broadband communication system. |
Basis of Presentation and Principles of Consolidation | The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation. In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income and cash flows. The consolidated balance sheet as of December 31, 2017 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on February 20, 2018, or the Annual Report. Interim results for the three months ended March 31, 2018 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2018 . |
Use of Estimates | The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to unaudited consolidated financial statements. Actual results could differ from those estimates. |
Significant Accounting Policies [Text Block] | Refer to the Company’s Annual Report for a summary of significant accounting policies. On January 1, 2018, the Company adopted Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 606, Revenue from Contracts with Customers , or ASC 606 and accordingly, modified its policy on revenue recognition as stated below . The primary impact of adopting ASC 606 for the Company was to accelerate the timing of the Company’s revenue and related cost recognition on products sold via some of its distributors, which changed from recognition upon the sale to the distributors' end customers, or the sell-through method, to recognition upon the Company's sale to the distributor, or the sell-in method. The Company is now also required to estimate the effects of pricing credits to its distributors from contractual price protection and unit rebate provisions, as well as stock rotation rights and record such estimated credits upon the Company's sale to the distributor. There have been no other material changes to our significant accounting policies during the three months ended March 31, 2018 . |
Revenue Recognition, Policy [Policy Text Block] | All of the Company's revenue is generated from sales of the Company’s integrated circuits to electronics distributors, module makers, OEMs, and ODMs under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product sales. Effective January 1, 2018, the Company adopted ASC 606 and recognizes revenue at the point in time when control of the products is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer's rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company's product sales, transfer of control occurs upon shipment to the distributor or direct customer. In assessing whether collection of consideration from a customer is probable, the Company considers the customer's ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component. A five-step approach is applied in the recognition of revenue under ASC 606: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. The Company applied ASC 606 to its customer contracts that were not completed before the January 1, 2018 adoption date. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach under ASC 606. Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time of control transfers using the expected value method based on the Company's analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company's sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company's current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company's general assurance warranty of products for a period of one to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company's customers resell our product as part of their product and thus are tax-exempt; however, to the extent the Company collects and remits taxes on product sales form customers, it has elected to exclude from the measurement of transaction price such taxes. Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has opted to not disclose the portion of revenues allocated to partially unsatisfied performance obligations, which represent products to be shipped within 12 months under open customer purchase orders, at the end of the current reporting period as allowed under ASC 606. The Company has also elected to record sales commissions when incurred, pursuant to the practical expedient under ASC 340, as the period over which the sales commission asset that would have been recognized is less than one year. Customer contract liabilities consist of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers consist of estimates of price protection rights offered to the Company's end customers, which are included in accrued price protection liability in the consolidated balance sheets, as well as price adjustments expected to be claimed by the distributor upon sell-through of the products to their customers, and amounts expected to be returned by distributors under stock rotation rights, which are included in accrued expenses and other current liabilities in the consolidated balance sheets. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately one to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12 . The Company assesses customer accounts receivable for impairment in accordance with ASC 310-10-35. The following tables present the amounts by which each financial statement line item was affected as a result of applying ASC 606: Three Months Ended March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands, except per share amounts) Consolidated statement of income: Net revenue $ 97,481 $ 13,346 $ 110,827 Cost of net revenue 42,992 5,167 48,159 Gross profit 54,489 8,179 62,668 Income (loss) from operations (3,749 ) 8,179 4,430 Loss before income taxes (8,196 ) 8,179 (17 ) Income tax benefit (3,582 ) 1,718 (1,864 ) Net income (loss) (4,614 ) 6,461 1,847 Basic earnings (loss) per share (0.07 ) 0.10 0.03 Diluted earnings (loss) per share (0.07 ) 0.10 0.03 March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands) Consolidated balance sheet: Accounts receivable $ 91,604 $ (972 ) $ 90,632 Inventory 45,679 79 45,758 Total current assets 201,958 (893 ) 201,065 Total assets 809,607 (893 ) 808,714 Deferred revenue and deferred profit 20,159 (20,159 ) — Accrued expenses and other current liabilities 14,542 11,171 25,713 Total current liabilities 76,049 (8,988 ) 67,061 Total liabilities 411,254 (8,988 ) 402,266 Accumulated deficit (73,838 ) 8,095 (65,743 ) Total stockholders' equity 398,353 8,095 406,448 Total liabilities and stockholders' equity 809,607 (893 ) 808,714 The impacts of adopting ASC 606 as shown above were primarily related to the acceleration of the timing of the Company’s revenue and related cost recognition on products sold via some of its distributors, which changed from sale to the distributors' end customers, or the sell-through method, to recognition upon the Company's sale to the distributor, or the sell-in method. Revenues from sales through the Company’s distributors accounted for 39% and 23% of net revenue for the three months ended March 31, 2018 and 2017 , respectively. |
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] | As of March 31, 2018 and December 31, 2017 , the Company has restricted cash of $1.7 million and $2.5 million , respectively. The restricted cash is on deposit in connection with guarantees for certain import duties and office leases. |
New Accounting Pronouncements, Policy [Policy Text Block] | In May 2014, the FASB, issued Accounting Standards Update, or ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which provides for new accounting guidance related to revenue recognition. This new standard replaced all prior U.S. GAAP guidance on this topic and eliminated all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance became effective for the Company on January 1, 2018 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company applied the guidance prospectively with an adjustment to accumulated deficit for the cumulative effect of adoption. Adoption of the amendments in this guidance accelerated the timing of the Company’s revenue and related cost recognition on products sold via some distributors, which changed from the sell-through method to the sell-in method under this guidance. The Company is also required to estimate the effects of pricing credits to its distributors from contractual price protection and unit rebate provisions, as well as stock rotation rights. The Company has performed an assessment of the impact of adopting this new accounting standard on its consolidated financial position and results of operations. The impact of adoption of this new accounting standard for the year ending December 31, 2018 will vary depending on the level of inventory remaining at December 31, 2018 at distributors for which the Company previously recognized revenue on a sell-through basis, and therefore could have a material impact on the Company's revenues for the year ending December 31, 2018. The impact to accumulated deficit as of January 1, 2018 was not material. As a result of applying the guidance prospectively with an adjustment to accumulated deficit in the Company's consolidated financial statements for the cumulative effect of adoption, revenues that would have been recognized on a sell-through basis for the amount of deferred revenue and profit remaining as of the adoption date will not be recognized in earnings for any period. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities . The amendments in this update include, among other things, a requirement to (1) measure equity investments (except equity method investments) at fair value with changes in fair value recognized in net income, with an option to measure equity investments that do not have readily determinable fair values at cost minus any impairment plus or minus any changes resulting from observable price changes; previously changes in fair value were recognized in other comprehensive income, and (2) separately present financial assets and liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statement. The amendments in this update were effective for the Company beginning in the first quarter of fiscal year 2018. The adoption of the amendments in this update did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. In March 2016, the FASB issued ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net ) to clarify the revenue recognition implementation guidance on principal versus agent considerations. The amendments in this update clarify that when another party is involved in providing goods or services to a customer, an entity that is the principal has obtained control of a good or service before it is transferred to a customer, and provides indicators to assist an entity in determining whether it controls a specified good or service prior to the transfer to the customer. An entity that is the principal recognizes revenue in the gross amount of consideration to which it expects to be entitled in exchange for the specified good or service transferred to the customer, whereas an agent recognizes revenue in the amount of any fee or commission to which it expects to be entitled in exchange for arranging for the specified good or service to be provided by the other party. The amendments in this update were effective for the Company beginning in the first quarter of fiscal year 2018, concurrent with and applied on the same basis as the new revenue recognition standard. The adoption of the amendments in this update did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments to eliminate the diversity in practice regarding the presentation and classification of certain cash receipts and cash payments, including, among other things, contingent consideration payments made following a business combination, proceeds from the settlement of insurance claims in the statement of cash flows, and debt prepayment or debt extinguishment costs. Cash payments not made soon after the acquisition date up to the amount of the contingent consideration liability recognized at the acquisition date, with any excess payments classified as operating activities, whereas cash payments made soon after the acquisition date to settle the contingent consideration should be classified as investing activities and cash payments for debt prepayment or debt extinguishment costs should be classified as financing activities. Cash proceeds received from settlement of insurance claims should be classified on the basis of the nature of the related losses. The amendments in this update should be applied using a retrospective transition method to each period presented, unless impracticable, and if impracticable, would be applied prospectively as of the earliest date practicable. The amendments in this update were effective for fiscal years beginning with fiscal year 2018, including interim periods within those years. The adoption of the amendments in this update did not have a material impact on the Company's consolidated statements of cash flows for the three months ended March 31, 2018 . In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The amendments in this update require the Company to account for the effects of a modification in a stock-based award unless the fair value, vesting conditions and classification of the modified award is the same as those of the original award immediately before the original award is modified. If the modification does not affect any of the inputs to the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification. The amendments in this update were effective for the Company for fiscal years beginning with fiscal year 2018, including interim periods within those years, with early adoption permitted in any interim period. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. The adoption of this guidance did not have a material impact on the Company's consolidated financial position and results of operations for the three months ended March 31, 2018. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act, or the Tax Act. The Tax Act makes broad and complex changes to the U.S. tax code. On December 22, 2017, the U.S. Securities and Exchange Commission Staff, or SEC Staff, issued guidance in Staff Accounting Bulletin No. 118, or SAB 118, to address certain fact patterns where the accounting for changes in tax laws or tax rates under ASC Topic 740 is incomplete upon issuance of an entity's financial statements for the reporting period in which the Tax Act is enacted. As permitted in SAB 118, in 2017, the Company took a measurement period approach and reported certain provisional amounts, based on reasonable estimates, for certain tax effects in which the accounting under ASC 740 is incomplete. Such provisional amounts are subject to adjustment during a limited measurement period, not to extend one year beyond the tax law enactment date, until the accounting under ASC 740 is complete. The Company also made required supplemental disclosures in the notes to the 2017 consolidated financial statements to accompany the provisional amounts, including the reasons for the incomplete accounting, the additional information or analysis that is needed, and other information relevant to why the Company was not able to complete the accounting required under ASC 740 in a timely manner. For adjustments to previously reported provisional amounts made in the three months ended March 31, 2018, refer to Note 10 . Additional adjustments to such reported provisional amounts could result in a material adverse impact to the Company's consolidated financial position and results of operations in 2018. In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. The amendments in this update are effective for the Company beginning in fiscal 2019, including interim periods. Early adoption is permitted. The amendments should be applied either in the period of adoption or retrospectively to each period or periods in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company elected to early adopt this guidance in the three months ended March 31, 2018. The adoption of this guidance did not have a material impact on the Company's consolidated financial position and results of operations. In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 . The amendments in this update amend the SEC paragraphs included in Topic 740 to be consistent with the guidance in SAB 118, which the Company adopted in the three months ended December 31, 2017, as described above. |
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] | |
New Accounting Pronouncements and Changes in Accounting Principles [Text Block] | In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments in this update require a lessee to recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term for all leases with terms greater than twelve months. For leases less than twelve months, an entity is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The Company intends to make this election. The amendments in this update are effective for the Company for fiscal years beginning with fiscal year 2019, including interim periods within those years, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption of the amendments in this update on the Company’s consolidated financial position and results of operations; however, adoption of the amendments in this update is expected to have a material impact on the Company's consolidated financial position. In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment , to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination. Instead, under the amendments in this update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Board also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendments in this update are effective for the Company beginning with fiscal year 2020, including interim periods, with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of the amendments in this update is not expected to have a material impact on the Company's consolidated financial position and results of operations. |
Organization and Summary of S22
Organization and Summary of Significant Accounting Policies New Accounting Pronouncement Effect (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Income Statement [Abstract] | |
Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block] | March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands) Consolidated balance sheet: Accounts receivable $ 91,604 $ (972 ) $ 90,632 Inventory 45,679 79 45,758 Total current assets 201,958 (893 ) 201,065 Total assets 809,607 (893 ) 808,714 Deferred revenue and deferred profit 20,159 (20,159 ) — Accrued expenses and other current liabilities 14,542 11,171 25,713 Total current liabilities 76,049 (8,988 ) 67,061 Total liabilities 411,254 (8,988 ) 402,266 Accumulated deficit (73,838 ) 8,095 (65,743 ) Total stockholders' equity 398,353 8,095 406,448 Total liabilities and stockholders' equity 809,607 (893 ) 808,714 Three Months Ended March 31, 2018 Amounts under Legacy GAAP Impact of Adoption As reported (in thousands, except per share amounts) Consolidated statement of income: Net revenue $ 97,481 $ 13,346 $ 110,827 Cost of net revenue 42,992 5,167 48,159 Gross profit 54,489 8,179 62,668 Income (loss) from operations (3,749 ) 8,179 4,430 Loss before income taxes (8,196 ) 8,179 (17 ) Income tax benefit (3,582 ) 1,718 (1,864 ) Net income (loss) (4,614 ) 6,461 1,847 Basic earnings (loss) per share (0.07 ) 0.10 0.03 Diluted earnings (loss) per share (0.07 ) 0.10 0.03 |
Net Income (Loss) Per Share (Ta
Net Income (Loss) Per Share (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Earnings Per Share [Abstract] | |
Summary of Basic and Diluted Earnings Per Share | Three Months Ended March 31, 2018 2017 (in thousands, except per share amounts) Numerator: Net income $ 1,847 $ 8,463 Denominator: Weighted average common shares outstanding—basic 67,674 65,238 Dilutive common stock equivalents 2,766 3,911 Weighted average common shares outstanding—diluted 70,440 69,149 Net income per share: Basic $ 0.03 $ 0.13 Diluted $ 0.03 $ 0.12 |
Business Combinations Business
Business Combinations Business Combinations (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Business Acquisition [Line Items] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | The following is an allocation of purchase price as of the May 12, 2017 closing date under the acquisition method of accounting. The purchase price allocation is based upon a preliminary estimate of the fair value of the assets acquired and the liabilities assumed by MaxLinear in the acquisition (in thousands): Description Amount Preliminary purchase price allocation: Cash $ 235,810 Accounts receivable 11,363 Inventory 48,536 Prepaid and other current assets 2,288 Property and equipment 3,442 Identifiable intangible assets 249,500 Deferred tax assets 7,675 Other assets 5,434 Accounts payable (12,385 ) Accrued expenses and other current liabilities (10,464 ) Accrued compensation (5,253 ) Other long-term liabilities (3,030 ) Identifiable net assets acquired 532,916 Goodwill 159,811 Total purchase price $ 692,727 |
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] | Estimated Useful Life (in years) Fair Value (in thousands) Developed technology 7.0 $ 120,900 Trademarks and tradenames 6.0 12,100 Customer-related intangible 5.0 96,300 Product backlog 0.5 3,600 Finite-lived intangible assets 6.0 232,900 In-process research and development N/A 16,600 Total intangible assets $ 249,500 |
Schedule of Business Acquisitions by Acquisition, Consideration [Table Text Block] | The following table summarizes the fair value of purchase price consideration to acquire Exar (in thousands): Acquisition Consideration Amount Cash (1) $ 688,114 Fair value of vested stock-based awards assumed (2) 4,613 Total $ 692,727 __________________ (1) Cash consideration paid includes 51,953,635 shares ultimately tendered at $13.00 per share, or an aggregate total of $675.4 million , plus $12.7 million of cash paid to settle certain outstanding stock-based awards which were not assumed by MaxLinear in the merger. (2) MaxLinear assumed certain of Exar's outstanding stock-based awards as part of the merger, and estimated the fair value of such assumed stock-based awards. The portion allocated to purchase price consideration represents the vested assumed stock-based awards. The fair value of the MaxLinear equivalent stock options included in stock-based awards assumed was estimated using the Black-Scholes valuation model utilizing certain assumptions. Such assumptions are based on MaxLinear’s best estimates, which impact the fair value of the options calculated under the Black-Scholes methodology and, ultimately, the total consideration recorded for the acquisition. |
Restructuring Activity (Tables)
Restructuring Activity (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] | The following table presents a roll-forward of the Company's restructuring liability for the three months ended March 31, 2018 . The restructuring liability is included in accrued expenses and other current liabilities in the consolidated balance sheets. Employee Separation Expenses Lease Related Charges Other Total (in thousands) Liability as of December 31, 2017 $ 239 $ 2,693 $ 107 $ 3,039 Cash payments (172 ) (570 ) — (742 ) Non-cash items (25 ) (27 ) (70 ) (122 ) Liability as of March 31, 2018 $ 42 $ 2,096 $ 37 $ 2,175 |
Goodwill and Intangibles Assets
Goodwill and Intangibles Assets (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill [Table Text Block] | Carrying Amount (in thousands) Balance as of December 31, 2017 $ 237,992 Adjustments (182 ) Balance as of March 31, 2018 $ 237,810 |
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] | The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: March 31, 2018 December 31, 2017 Weighted Average Useful Life (in Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) Licensed technology 3.7 $ 2,070 $ (718 ) $ 1,352 $ 2,070 $ (575 ) $ 1,495 Developed technology 6.9 241,561 (48,220 ) 193,341 241,561 (39,252 ) 202,309 Trademarks and trade names 6.1 13,800 (2,557 ) 11,243 13,800 (1,992 ) 11,808 Customer relationships 4.6 121,100 (33,908 ) 87,192 121,100 (26,661 ) 94,439 Non-compete covenants 3.0 1,100 (597 ) 503 1,100 (506 ) 594 6.1 $ 379,631 $ (86,000 ) $ 293,631 $ 379,631 $ (68,986 ) $ 310,645 |
Finite-lived Intangible Assets Amortization Expense [Table Text Block] | The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of income as follows: Three Months Ended March 31, 2018 2017 (in thousands) Cost of net revenue $ 8,978 $ 2,684 Research and development 42 137 Selling, general and administrative 7,994 1,881 $ 17,014 $ 4,702 |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | The following table sets forth the activity during the three months ended March 31, 2018 related to finite-lived intangible assets resulting from amortization: Carrying Amount (in thousands) Balance as of December 31, 2017 $ 310,645 Amortization (17,014 ) Balance as of March 31, 2018 $ 293,631 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2018 : Amount (in thousands) 2018 (9 months) $ 51,027 2019 57,191 2020 56,325 2021 55,542 2022 38,012 Thereafter 35,534 Total $ 293,631 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Fair Value Disclosures [Abstract] | |
Available-for-sale Securities [Table Text Block] | The composition of financial instruments is as follows: March 31, 2018 December 31, 2017 (in thousands) Assets Interest rate swap $ 2,118 $ 734 |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following table presents a summary of the Company’s financial instruments that were measured at fair value on a recurring basis and the related level of the fair value hierarchy: Fair Value Measurements Balance Quoted Prices Significant Significant (in thousands) Interest rate swap, March 31, 2018 $ 2,118 $ — $ 2,118 $ — Interest rate swap, December 31, 2017 $ 734 $ — $ 734 $ — |
Derivative Instruments and Hedging Activities Disclosure [Text Block] | The following table summarizes activity for the interest rate swap: Three Months Ended March 31, March 31, (in thousands) Interest rate swap asset Beginning balance $ 734 $ — Unrealized gain included in other comprehensive income 1,384 — Ending balance $ 2,118 $ — |
Balance Sheet Details (Tables)
Balance Sheet Details (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Balance Sheet Related Disclosures [Abstract] | |
Cash, Cash Equivalents and Investments | Cash, cash equivalents and restricted cash consist of the following: March 31, 2018 December 31, 2017 (in thousands) Cash and cash equivalents $ 55,645 $ 71,872 Short-term restricted cash 617 1,476 Long-term restricted cash 1,071 1,064 Total cash, cash equivalents and restricted cash $ 57,333 $ 74,412 |
Inventory | Inventory consists of the following: March 31, 2018 December 31, 2017 (in thousands) Work-in-process $ 21,102 $ 21,823 Finished goods 24,518 31,611 Inventory expected to be received from distributors as returns 138 — $ 45,758 $ 53,434 |
Property and Equipment | Property and equipment, net consists of the following: Useful Life March 31, 2018 December 31, 2017 (in thousands) Furniture and fixtures 5 $ 2,103 $ 2,105 Machinery and equipment 3-5 34,221 33,462 Masks and production equipment 2 11,788 11,470 Software 3 4,704 4,695 Leasehold improvements 1-5 14,271 14,340 Construction in progress N/A 1,980 639 69,067 66,711 Less accumulated depreciation and amortization (47,074 ) (44,053 ) $ 21,993 $ 22,658 |
Deferred Revenue and Deferred Profit | Deferred revenue and deferred profit consist of the following: March 31, 2018 December 31, 2017 (1) (in thousands) Deferred revenue—rebates $ — $ 156 Deferred revenue—distributor transactions — 5,341 Deferred cost of net revenue—distributor transactions — (1,135 ) $ — $ 4,362 |
Price Protection Liability | ccrued price protection liability consists of the following activity: Three Months Ended March 31, 2018 2017 (in thousands) Beginning balance $ 21,571 $ 15,176 Charged as a reduction of revenue 10,744 11,698 Reversal of unclaimed rebates (2,367 ) — Payments (9,736 ) (4,927 ) Ending balance $ 20,212 $ 21,947 |
Accrued Expenses | Accrued expenses and other current liabilities consist of the following: March 31, 2018 December 31, 2017 (1) (in thousands) Accrued technology license payments $ 4,500 $ 4,500 Accrued professional fees 857 1,497 Accrued engineering and production costs 618 2,378 Accrued restructuring 2,175 3,039 Accrued royalty 1,027 1,206 Accrued leases—other 1,129 1,105 Accrued customer credits 1,315 2,667 Customer contract liabilities 114 — Accrued obligations to customers for price adjustments 10,729 — Accrued obligations to customers for stock rotation rights 1,077 — Other 2,172 3,914 $ 25,713 $ 20,306 ___________ (1) Due to the adoption of ASC 606 using the modified retrospective method, prior period amounts have not been adjusted to include customer contract liabilities and accrued obligations to customers for price adjustments and stock rotation rights, which are now required to be estimated and disclosed at the time of sale. |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Schedule of Debt [Table Text Block] | he carrying amount of the Company's long-term debt consists of the following: March 31, December 31, (in thousands) Principal $ 330,000 $ 355,000 Less: Unamortized debt discount (1,855 ) (1,930 ) Unamortized debt issuance costs (5,249 ) (5,461 ) Net carrying amount of long-term debt 322,896 347,609 Less: current portion of long-term debt — — Long-term debt, non-current portion $ 322,896 $ 347,609 |
Stock-Based Compensation and Em
Stock-Based Compensation and Employee Benefit Plans (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation | The Company recognizes stock-based compensation in the consolidated statements of income, based on the department to which the related employee reports, as follows: Three Months Ended March 31, 2018 2017 (in thousands) Cost of net revenue $ 106 $ 59 Research and development 4,374 3,493 Selling, general and administrative 3,993 1,922 $ 8,473 $ 5,474 |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] | Number of Shares (in thousands) Weighted-Average Grant-Date Fair Value per Share Outstanding at December 31, 2017 3,183 $ 20.13 Granted 397 23.42 Vested (663 ) 19.97 Canceled (58 ) 22.36 Outstanding at March 31, 2018 2,859 20.61 |
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] | Three Months Ended March 31, 2018 Weighted-average grant date fair value per share $ 6.51 Risk-free interest rate 1.39 % Dividend yield — % Expected life (in years) 0.50 Volatility 36.97 % |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | A summary of the Company’s stock options activity is as follows: Number of Options (in thousands) Weighted-Average Exercise Price Weighted-Average Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at December 31, 2017 3,069 $ 8.95 Exercised (129 ) 7.63 Canceled (5 ) 18.40 Outstanding at March 31, 2018 2,935 $ 8.99 2.36 $ 40,641 Vested and expected to vest at March 31, 2018 2,899 $ 8.90 2.33 $ 40,413 Exercisable at March 31, 2018 2,559 $ 8.07 2.03 $ 37,767 |
Significant Customer and Geogra
Significant Customer and Geographic Information (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Risks and Uncertainties [Abstract] | |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | Three Months Ended March 31, 2018 2017 Percentage of total net revenue Customer A 27 % 31 % Balances that are 10% or greater of accounts receivable, based on the Company's billings to the contract manufacturer customers, are as follows: March 31, December 31, 2018 2017 Percentage of gross accounts receivable Customer A 10 % * Customer B 13 % 17 % Customer C * 10 % Suppliers comprising greater than 10% of total inventory purchases are as follows: Three Months Ended March 31, 2018 2017 Vendor A 21 % 21 % Vendor B 19 % 19 % Vendor C * 15 % Vendor D 16 % 12 % Vendor E 14 % 17 % The products shipped to individual countries representing greater than 10% of net revenue for each of the periods presented are as follows: Three Months Ended March 31, 2018 2017 Percentage of total net revenue China 61 % 78 % |
Revenue from External Customers by Geographic Areas [Table Text Block] | The Company's consolidated net revenues by geographic area based on ship-to location are as follows: Three Months Ended March 31, 2018 2017 Amount % of total net revenue Amount % of total net revenue Asia $ 84,814 77 % $ 84,332 95 % United States 5,195 5 % 145 — % Rest of world 20,818 19 % 4,364 5 % Total $ 110,827 100 % $ 88,841 100 % |
Long-lived Assets by Geographic Areas [Table Text Block] | Long-lived assets, which consists of property and equipment, net, intangible assets, net, and goodwill by geographic area are as follows (in thousands): March 31, December 31, 2018 2017 Amount % of total Amount % of total United States $ 468,774 84 % $ 481,638 84 % Singapore 87,187 16 % 92,414 16 % Rest of world 2,055 — % 1,643 — % Total $ 558,016 100 % $ 575,695 100 % |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Future Minimum Payments Under Operating Leases | As of March 31, 2018 , future minimum payments under non-cancelable operating leases, inventory purchase and other obligations are as follows: Operating Leases Inventory Purchase Obligations Other Obligations Total (in thousands) 2018 (9 months) $ 6,631 $ 49,183 $ 5,651 $ 61,465 2019 9,242 — 7,761 17,003 2020 9,444 — 3,781 13,225 2021 9,238 — 30 9,268 2022 5,102 — — 5,102 Thereafter 792 — — 792 Total minimum payments $ 40,449 $ 49,183 $ 17,223 $ 106,855 Amount (in thousands) 2018 (9 months) $ 2,184 2019 3,604 2020 4,088 2021 4,152 2022 879 Thereafter 352 Total minimum rental income $ 15,259 |
Future Minimum Payments Under Other Obligations | As of March 31, 2018 , future minimum payments under non-cancelable operating leases, inventory purchase and other obligations are as follows: Operating Leases Inventory Purchase Obligations Other Obligations Total (in thousands) 2018 (9 months) $ 6,631 $ 49,183 $ 5,651 $ 61,465 2019 9,242 — 7,761 17,003 2020 9,444 — 3,781 13,225 2021 9,238 — 30 9,268 2022 5,102 — — 5,102 Thereafter 792 — — 792 Total minimum payments $ 40,449 $ 49,183 $ 17,223 $ 106,855 |
Future Minimum Payments Under Inventory Purchase Obligations | As of March 31, 2018 , future minimum payments under non-cancelable operating leases, inventory purchase and other obligations are as follows: Operating Leases Inventory Purchase Obligations Other Obligations Total (in thousands) 2018 (9 months) $ 6,631 $ 49,183 $ 5,651 $ 61,465 2019 9,242 — 7,761 17,003 2020 9,444 — 3,781 13,225 2021 9,238 — 30 9,268 2022 5,102 — — 5,102 Thereafter 792 — — 792 Total minimum payments $ 40,449 $ 49,183 $ 17,223 $ 106,855 |
Revenue from Contracts with C33
Revenue from Contracts with Customers (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Revenue from Contracts with Customers [Abstract] | |
Revenue from External Customers by Products and Services [Table Text Block] | The table below presents disaggregated net revenues by market (in thousands): Three months ended March 31, 2018 2017 (1) Connected home $ 65,658 $ 77,240 % of net revenue 59 % 87 % Infrastructure 20,490 11,534 % of net revenue 19 % 13 % Industrial and multi-market 24,679 67 % of net revenue 22 % — % Total net revenue $ 110,827 $ 88,841 |
Concentration Risk Disclosure [Text Block] | Concentration of Credit Risk, Significant Customers and Revenue by Geographic Region Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents. Significant Customers The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company makes periodic evaluations of the credit worthiness of its customers. Customers comprising greater than 10% of net revenues for each of the periods presented are as follows: Three Months Ended March 31, 2018 2017 Percentage of total net revenue Customer A 27 % 31 % Balances that are 10% or greater of accounts receivable, based on the Company's billings to the contract manufacturer customers, are as follows: March 31, December 31, 2018 2017 Percentage of gross accounts receivable Customer A 10 % * Customer B 13 % 17 % Customer C * 10 % ____________________________ * Represents less than 10% of the gross accounts receivable as of the respective period end. Suppliers comprising greater than 10% of total inventory purchases are as follows: Three Months Ended March 31, 2018 2017 Vendor A 21 % 21 % Vendor B 19 % 19 % Vendor C * 15 % Vendor D 16 % 12 % Vendor E 14 % 17 % ____________________________ * Represents less than 10% of the inventory purchases for the respective period. Geographic Information The Company's consolidated net revenues by geographic area based on ship-to location are as follows: Three Months Ended March 31, 2018 2017 Amount % of total net revenue Amount % of total net revenue Asia $ 84,814 77 % $ 84,332 95 % United States 5,195 5 % 145 — % Rest of world 20,818 19 % 4,364 5 % Total $ 110,827 100 % $ 88,841 100 % The products shipped to individual countries representing greater than 10% of net revenue for each of the periods presented are as follows: Three Months Ended March 31, 2018 2017 Percentage of total net revenue China 61 % 78 % The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country in Asia Pacific, United States, or the rest of the world accounted for more than 10% of net revenue during these periods. Long-lived assets, which consists of property and equipment, net, intangible assets, net, and goodwill by geographic area are as follows (in thousands): March 31, December 31, 2018 2017 Amount % of total Amount % of total United States $ 468,774 84 % $ 481,638 84 % Singapore 87,187 16 % 92,414 16 % Rest of world 2,055 — % 1,643 — % Total $ 558,016 100 % $ 575,695 100 % |
Organization and Summary of S34
Organization and Summary of Significant Accounting Policies (Details Textuals) - USD ($) $ / shares in Units, shares in Thousands | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
New Accounting Pronouncement, Early Adoption [Line Items] | |||
Accounts receivable, net | $ 90,632,000 | $ 66,099,000 | |
Inventory | 45,758,000 | 53,434,000 | |
Assets, Current | 201,065,000 | 201,304,000 | |
Assets | 808,714,000 | 824,862,000 | |
Deferred revenue and deferred profit | 0 | 4,362,000 | |
Accrued expenses and other current liabilities | 25,713,000 | 20,306,000 | |
Liabilities, Current | 67,061,000 | 76,386,000 | |
Total liabilities | 402,266,000 | 437,438,000 | |
Revenue, Net | 110,827,000 | $ 88,841,000 | |
Cost of net revenue | 48,159,000 | 35,917,000 | |
Gross Profit | 62,668,000 | 52,924,000 | |
Operating Income (Loss) | 4,430,000 | 10,433,000 | |
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | (17,000) | 10,484,000 | |
Income tax provision (benefit) | (1,864,000) | 2,021,000 | |
Net Income (Loss) Attributable to Parent | $ 1,847,000 | $ 8,463,000 | |
Basic | $ 0.03 | $ 0.13 | |
Diluted | $ 0.03 | $ 0.12 | |
Diluted | 70,440 | 69,149 | |
Accumulated deficit | $ (65,743,000) | (69,119,000) | |
Total stockholders’ equity | 406,448,000 | 387,424,000 | |
Liabilities and Equity | 808,714,000 | $ 824,862,000 | |
Previous Accounting Guidance [Member] | |||
New Accounting Pronouncement, Early Adoption [Line Items] | |||
Accounts receivable, net | 91,604,000 | ||
Inventory | 45,679,000 | ||
Assets, Current | 201,958,000 | ||
Assets | 809,607,000 | ||
Deferred revenue and deferred profit | 20,159,000 | ||
Accrued expenses and other current liabilities | 14,542,000 | ||
Liabilities, Current | 76,049,000 | ||
Total liabilities | 411,254,000 | ||
Revenue, Net | 97,481,000 | ||
Cost of net revenue | 42,992,000 | ||
Gross Profit | 54,489,000 | ||
Operating Income (Loss) | (3,749,000) | ||
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | (8,196,000) | ||
Income tax provision (benefit) | (3,582,000) | ||
Net Income (Loss) Attributable to Parent | $ (4,614,000) | ||
Basic | $ (0.07) | ||
Diluted | $ (0.07) | ||
Accumulated deficit | $ (73,838,000) | ||
Total stockholders’ equity | 398,353,000 | ||
Liabilities and Equity | 809,607,000 | ||
Impact of New Accounting Guidance [Member] | |||
New Accounting Pronouncement, Early Adoption [Line Items] | |||
Accounts receivable, net | (972,000) | ||
Inventory | 79,000 | ||
Assets, Current | (893,000) | ||
Assets | (893,000) | ||
Deferred revenue and deferred profit | (20,159,000) | ||
Accrued expenses and other current liabilities | 11,171,000 | ||
Liabilities, Current | (8,988,000) | ||
Total liabilities | (8,988,000) | ||
Revenue, Net | 13,346,000 | ||
Cost of net revenue | 5,167,000 | ||
Gross Profit | 8,179,000 | ||
Operating Income (Loss) | 8,179,000 | ||
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | 8,179,000 | ||
Income tax provision (benefit) | 1,718,000 | ||
Net Income (Loss) Attributable to Parent | $ 6,461,000 | ||
Basic | $ 0.10 | ||
Diluted | $ 0.10 | ||
Accumulated deficit | $ 8,095,000 | ||
Total stockholders’ equity | 8,095,000 | ||
Liabilities and Equity | (893,000) | ||
Revenue from Distributors [Member] | |||
New Accounting Pronouncement, Early Adoption [Line Items] | |||
Sales Revenue, Goods, Net | $ 0.39 | $ 0.23 |
Net Income (Loss) Per Share (De
Net Income (Loss) Per Share (Details 1) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Numerator: | ||
Net income (loss) | $ 1,847 | $ 8,463 |
Denominator: | ||
Dilutive common stock equivalents (shares) | 2,766 | 3,911 |
Weighted average common shares outstanding-diluted (shares) | 70,440 | 69,149 |
Net income per share: | ||
Basic | $ 0.03 | $ 0.13 |
Diluted | $ 0.03 | $ 0.12 |
Net Income (Loss) Per Share (36
Net Income (Loss) Per Share (Details Textuals) - shares shares in Millions | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Earnings Per Share [Abstract] | ||
Common stock equivalents excluded from the calculation of net loss per share (shares) | 1 | 0.4 |
Business Combinations Busines37
Business Combinations Business Combination - Exar (Details) - USD ($) $ / shares in Units, $ in Thousands | May 12, 2017 | Mar. 31, 2018 | Dec. 31, 2017 | Nov. 09, 2016 |
Business Acquisition [Line Items] | ||||
Balance as of December 31, 2017 | $ 237,810 | $ 237,992 | ||
Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Goodwill, Purchase Accounting Adjustments | (182) | |||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 6 years | |||
Finite-lived Intangible Assets Acquired | $ 232,900 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | 235,810 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables | 11,363 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory | 48,536 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | 2,288 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment | 3,442 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill | 249,500 | |||
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets | 7,675 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets | 5,434 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable | (12,385) | |||
Business Combination, Recognized Identifiable Assets and Liabilities Assumed, Accrued Expenses and Other Current Liabilities | (10,464) | |||
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Compensation | (5,253) | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other | (3,030) | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | 532,916 | |||
Balance as of December 31, 2017 | 159,811 | |||
Business Combination, Purchase price | 692,727 | |||
Business Combination, Finite and Indefinite Lived Intangible Assets Acquired | $ 249,500 | |||
Business Acquisition, Effective Date of Acquisition | May 12, 2017 | |||
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Fair Value Mark Up On Inventory | $ 24,286 | |||
Business Combination, Indemnification Assets, Amount as of Acquisition Date | 5,000 | $ 5,000 | ||
Business Acquisition, Name of Acquired Entity | Exar Corporation | |||
Business Combination, Consideration Transferred | $ 692,727 | |||
Proceeds from Issuance of Debt | $ 416,800 | |||
Long-term Debt, Gross | $ 425,000 | |||
Business acquisition, Shares Tendered | 51,953,635 | |||
Exar Corporation [Member] | Common Stock [Member] | ||||
Business Acquisition [Line Items] | ||||
Business Acquisition, Share Price | $ 13 | |||
Cash [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Business Combination, Consideration Transferred | $ 688,114 | |||
Cash in lieu of equity [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Business Combination, Consideration Transferred | 12,717 | |||
Stock Based Awards [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $ 4,613 | |||
Customer Relationships [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 5 years | |||
Finite-lived Intangible Assets Acquired | $ 96,300 | |||
Order or Production Backlog [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 6 months | |||
Finite-lived Intangible Assets Acquired | $ 3,600 | |||
Developed technology | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 7 years | |||
Finite-lived Intangible Assets Acquired | $ 120,900 | |||
Trademarks and Trade Names [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 6 years | |||
Finite-lived Intangible Assets Acquired | $ 12,100 | |||
In Process Research and Development [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Indefinite-lived Intangible Assets Acquired | 16,600 | |||
Cash [Member] | Exar Corporation [Member] | ||||
Business Acquisition [Line Items] | ||||
Business Acquisition, Tender Amount | $ 675,400 |
Business Combinations Busines38
Business Combinations Business Combination - G.hn Business of Marvell (Details) $ in Thousands | Apr. 04, 2017USD ($) |
G.hn business of Marvell [Member] | |
Business Acquisition [Line Items] | |
Payments to Acquire Businesses, Gross | $ 21,000 |
Business Combinations Pro-Forma
Business Combinations Pro-Forma (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Business Acquisition [Line Items] | ||
Net Income (Loss) Attributable to Parent | $ 1,847 | $ 8,463 |
Restructuring Activity (Details
Restructuring Activity (Details 2) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Dec. 31, 2017 | |
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Reserve | $ 2,175 | $ 3,039 |
Payments for Restructuring | (742) | |
Restructuring Reserve, Settled without Cash | (122) | |
Lease Related Impairment [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Reserve | 2,096 | 2,693 |
Payments for Restructuring | (570) | |
Restructuring Reserve, Settled without Cash | (27) | |
One-time Termination Benefits [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Reserve | 42 | 239 |
Payments for Restructuring | (172) | |
Restructuring Reserve, Settled without Cash | (25) | |
Other Restructuring [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Reserve | 37 | $ 107 |
Payments for Restructuring | 0 | |
Restructuring Reserve, Settled without Cash | $ (70) |
Goodwill and Intangibles Asse41
Goodwill and Intangibles Assets (Details 1) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Goodwill [Line Items] | ||
Balance as of December 31, 2017 | $ 237,810 | $ 237,992 |
Balance as of March 31, 2018 |
Goodwill and Intangibles Asse42
Goodwill and Intangibles Assets (Details 2) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
Finite-Lived Intangible Assets [Line Items] | |||
Amortization | $ 17,014 | $ 4,702 | |
Allocated Share-based Compensation Expense | $ 8,473 | 5,474 | |
Weighted Average Useful Life (in Years) | 6 years 1 month 6 days | ||
Gross Carrying Amount | $ 379,631 | $ 379,631 | |
Accumulated Amortization | (86,000) | (68,986) | |
Net Carrying Amount | $ 293,631 | 310,645 | |
Licensed technology | |||
Finite-Lived Intangible Assets [Line Items] | |||
Weighted Average Useful Life (in Years) | 3 years 8 months 12 days | ||
Gross Carrying Amount | $ 2,070 | 2,070 | |
Accumulated Amortization | (718) | (575) | |
Net Carrying Amount | $ 1,352 | 1,495 | |
Developed technology | |||
Finite-Lived Intangible Assets [Line Items] | |||
Weighted Average Useful Life (in Years) | 6 years 10 months 24 days | ||
Gross Carrying Amount | $ 241,561 | 241,561 | |
Accumulated Amortization | (48,220) | (39,252) | |
Net Carrying Amount | $ 193,341 | 202,309 | |
Trademarks and trade names | |||
Finite-Lived Intangible Assets [Line Items] | |||
Weighted Average Useful Life (in Years) | 6 years 1 month 6 days | ||
Gross Carrying Amount | $ 13,800 | 13,800 | |
Accumulated Amortization | (2,557) | (1,992) | |
Net Carrying Amount | $ 11,243 | 11,808 | |
Customer relationships | |||
Finite-Lived Intangible Assets [Line Items] | |||
Weighted Average Useful Life (in Years) | 4 years 7 months 6 days | ||
Gross Carrying Amount | $ 121,100 | 121,100 | |
Accumulated Amortization | (33,908) | (26,661) | |
Net Carrying Amount | $ 87,192 | 94,439 | |
Noncompete Agreements [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Weighted Average Useful Life (in Years) | 3 years | ||
Gross Carrying Amount | $ 1,100 | 1,100 | |
Accumulated Amortization | (597) | (506) | |
Net Carrying Amount | 503 | $ 594 | |
Cost of Sales [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization | 8,978 | 2,684 | |
Allocated Share-based Compensation Expense | 106 | 59 | |
Research and Development Expense [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization | 42 | 137 | |
Allocated Share-based Compensation Expense | 4,374 | 3,493 | |
Selling, General and Administrative Expenses [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization | 7,994 | 1,881 | |
Allocated Share-based Compensation Expense | $ 3,993 | $ 1,922 |
Goodwill and Intangibles Asse43
Goodwill and Intangibles Assets (Details 3) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Business Acquisition [Line Items] | ||
Finite-Lived Intangible Assets, Net - Beginning Balance | $ 310,645 | |
Amortization | 17,014 | $ 4,702 |
Finite-Lived Intangible Assets, Net - Ending Balance | $ 293,631 |
Goodwill and Intangibles Asse44
Goodwill and Intangibles Assets (Details 4) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year | $ 51,027 | |
Finite-Lived Intangible Assets, Amortization Expense, Year Two | 57,191 | |
Finite-Lived Intangible Assets, Amortization Expense, Year Three | 56,325 | |
Finite-Lived Intangible Assets, Amortization Expense, Year Four | 55,542 | |
Finite-Lived Intangible Assets, Amortization Expense, Year Five | 38,012 | |
Finite-Lived Intangible Assets, Amortization Expense, after Year Five | 35,534 | |
Finite-Lived Intangible Assets, Net | $ 293,631 | $ 310,645 |
Goodwill and Intangibles Asse45
Goodwill and Intangibles Assets (Details 5) | 3 Months Ended |
Mar. 31, 2018USD ($) | |
Indefinite-lived Intangible Assets [Line Items] | |
Impairment of IPR&D assets | $ 0 |
Indefinite-lived Intangible Assets [Member] | |
Indefinite-lived Intangible Assets [Line Items] | |
Transfers into developed technology from IPR&D | $ 0 |
Goodwill and Intangibles Asse46
Goodwill and Intangibles Assets (Details Textuals) - USD ($) | 3 Months Ended | |||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | May 12, 2017 | |
Impairment of IPR&D assets | $ 0 | |||
Balance as of December 31, 2017 | 237,810,000 | $ 237,992,000 | ||
Amortization | 17,014,000 | $ 4,702,000 | ||
Goodwill, Impairment Loss | 0 | |||
Impairment of Intangible Assets (Excluding Goodwill) | 0 | |||
Finite-Lived Intangible Assets [Member] | ||||
Transfers into developed technology from IPR&D | 0 | |||
Indefinite-lived Intangible Assets [Member] | ||||
Transfers into developed technology from IPR&D | 0 | |||
Exar Corporation [Member] | ||||
Goodwill, Purchase Accounting Adjustments | $ (182,000) | |||
Balance as of December 31, 2017 | $ 159,811,000 |
Financial Instruments (Details
Financial Instruments (Details 1) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | $ 2,118 | $ 734 | $ 0 | $ 0 |
Financial Instruments (Detail48
Financial Instruments (Details 2) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | $ 2,118,000 | $ 734,000 | $ 0 | $ 0 |
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Derivative Financial Instruments, Assets [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | 0 | 0 | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Derivative Financial Instruments, Assets [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | 2,118,000 | 734,000 | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Derivative Financial Instruments, Assets [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | 0 | 0 | ||
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Derivative Financial Instruments, Assets [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative Asset | $ 2,118,000 | $ 734,000 |
Financial Instruments (Detail49
Financial Instruments (Details 3) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Derivative Asset | $ 2,118 | $ 0 | $ 734 | $ 0 |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss) | $ 1,384 | $ 0 |
Financial Instruments - Additio
Financial Instruments - Additional Information (Details Textuals) | 3 Months Ended |
Mar. 31, 2018USD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | $ 0 |
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | 0 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | $ 0 |
Balance Sheet Details - Cash an
Balance Sheet Details - Cash and Investments (Details 1) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Balance Sheet Related Disclosures [Abstract] | ||||
Cash and cash equivalents | $ 55,645 | $ 71,872 | ||
Short-term restricted cash | 617 | 1,476 | ||
Long-term restricted cash | 1,071 | 1,064 | ||
Cash, cash equivalents and restricted cash | $ 57,333 | $ 74,412 | $ 91,238 | $ 82,896 |
Balance Sheet Details - Invento
Balance Sheet Details - Inventory (Details 2) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Balance Sheet Related Disclosures [Abstract] | ||
Work-in-process | $ 21,102 | $ 21,823 |
Finished goods | 24,518 | 31,611 |
Inventory, Distributor Returns | 138 | 0 |
Inventory Total | $ 45,758 | $ 53,434 |
Balance Sheet Details - Propert
Balance Sheet Details - Property and Equipment (Details 3) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
Property, Plant and Equipment [Line Items] | |||
Depreciation | $ 3,100 | $ 2,200 | |
Property and equipment, Gross | 69,067 | $ 66,711 | |
Less accumulated depreciation and amortization | (47,074) | (44,053) | |
Property and equipment, net | $ 21,993 | 22,658 | |
Furniture and fixtures [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 5 years | ||
Property and equipment, Gross | $ 2,103 | 2,105 | |
Machinery and equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, Gross | $ 34,221 | 33,462 | |
Machinery and equipment [Member] | Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 3 years | ||
Machinery and equipment [Member] | Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 5 years | ||
Masks and production equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 2 years | ||
Property and equipment, Gross | $ 11,788 | 11,470 | |
Software and Software Development Costs [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 3 years | ||
Property and equipment, Gross | $ 4,704 | 4,695 | |
Leasehold improvements [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, Gross | $ 14,271 | 14,340 | |
Leasehold improvements [Member] | Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 1 year | ||
Leasehold improvements [Member] | Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Useful life | 5 years | ||
Construction in progress [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, Gross | $ 1,980 | $ 639 |
Balance Sheet Details - Deferre
Balance Sheet Details - Deferred Revenue and Deferred Profit (Details 4) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Balance Sheet Related Disclosures [Abstract] | ||
Deferred revenue-rebates | $ 0 | $ 156 |
Deferred revenue - distributor transactions | 0 | 5,341 |
Deferred cost of net revenue - distributor transactions | 0 | (1,135) |
Deferred revenue and deferred profit | $ 0 | $ 4,362 |
Balance Sheet Details- Accrued
Balance Sheet Details- Accrued Price Protection Liability (Details 5) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Accrued Price Protection Rebate Activity [Roll Forward] | ||
Begining Balance | $ 21,571 | $ 15,176 |
Charged as a reduction of revenue | 10,744 | 11,698 |
Reversal of unclaimed rebates | (2,367) | 0 |
Payments | (9,736) | (4,927) |
Ending Balance | $ 20,212 | $ 21,947 |
Balance Sheet Details - Accrued
Balance Sheet Details - Accrued Expenses (Details 6) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Accrued technology license payments | $ 4,500 | $ 4,500 |
Accrued professional fees | 857 | 1,497 |
Accrued engineering and production costs | 618 | 2,378 |
Accrued restructuring | 2,175 | 3,039 |
Accrued royalty | 1,027 | 1,206 |
Accrued Rent, Current | 1,129 | 1,105 |
Accrued customer credits | 1,315 | 2,667 |
Customer contract liabilities | 114 | 0 |
Accrued obligations to customer for price protection | 10,729 | |
Accrued obligations to customers for stock rotation rights | 1,077 | |
Other | 2,172 | 3,914 |
Total | $ 25,713 | 20,306 |
Price Adjustments [Member] | ||
Accrued customer obligations | 0 | |
Stock Rotation Rights [Member] | ||
Accrued customer obligations | $ 0 |
Debt (Details)
Debt (Details) - USD ($) $ in Thousands | May 12, 2024 | Mar. 31, 2018 | Mar. 31, 2017 | Mar. 31, 2018 | Dec. 31, 2017 | Nov. 03, 2017 | May 12, 2017 | Dec. 31, 2016 |
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Term | 7 years | |||||||
Debt Instrument, Call Feature | 1.0% soft call premium | |||||||
Repayments of Debt | $ 95,000 | |||||||
Debt Issuance Costs, Gross | $ 6,000 | |||||||
Amortization of Debt Issuance Costs and Discounts | $ 287 | $ 0 | ||||||
Unsecured Long-term Debt, Noncurrent | 322,896 | 322,896 | $ 347,609 | |||||
Debt Instrument, Annual Principal Payment | $ 330,000 | $ 330,000 | ||||||
Derivative, Fixed Interest Rate | 4.25% | 4.25% | 1.74685% | |||||
Long-term Debt, Description | 160 | |||||||
Debt Instrument, Interest Rate, Effective Percentage | 4.30% | 4.30% | ||||||
Long-term Debt, Fair Value | $ 320,800 | $ 320,800 | 398,500 | |||||
Derivative Asset | $ 2,118 | $ 0 | 2,118 | 734 | $ 0 | |||
Debt Instrument, Interest Rate, Basis for Effective Rate | 0.046 | |||||||
Debt Instrument, Unamortized Discount | (2,100) | |||||||
Base Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | a base rate | |||||||
Base Rate [Member] | Applicable Margin - 1.5% [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | 0.015 | |||||||
Federal Funds Effective Swap Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | the federal funds rate, plus 0.50% | |||||||
Prime Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | prime rate | |||||||
London Interbank Offered Rate (LIBOR) [Member] | Applicable Margin - 2.5% [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | 0.025 | |||||||
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | adjusted LIBOR rate, subject to a floor of 0.75% | |||||||
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate Terms | an adjusted LIBOR rate determined on the basis of a one- three- or six-month interest period, plus 1.0% | |||||||
Medium-term Notes [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term Debt, Gross | $ 330,000 | 330,000 | 355,000 | $ 425,000 | ||||
Debt Issuance Costs, Net | (5,249) | (5,249) | (5,461) | |||||
Long-term Debt | 322,896 | 322,896 | 347,609 | |||||
Long-term Debt, Current Maturities | 0 | 0 | 0 | |||||
Unsecured Long-term Debt, Noncurrent | 322,896 | 322,896 | 347,609 | |||||
Debt Instrument, Unamortized Discount | $ (1,855) | $ (1,855) | $ (1,930) | |||||
Scenario, Forecast [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Frequency of Periodic Payment | quarterly installments | |||||||
Debt Instrument, Payment Terms | 0.0025 |
Stock-Based Compensation and 58
Stock-Based Compensation and Employee Benefit Plans - Expense by Type (Details 1) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | $ 8,473 | $ 5,474 |
Cost of Sales [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | 106 | 59 |
Research and Development Expense [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | 4,374 | 3,493 |
Selling, General and Administrative Expenses [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | $ 3,993 | $ 1,922 |
Stock-Based Compensation and 59
Stock-Based Compensation and Employee Benefit Plans - Awards (Details 2) shares in Thousands | 3 Months Ended |
Mar. 31, 2018$ / sharesshares | |
Employee Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 6 months |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 6.51 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 36.97% |
Restricted Stock Unit and Restricted Stock Award [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 3,183 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 397 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | (663) |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | (58) |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 2,859 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 20.13 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | 23.42 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share | 19.97 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value | 22.36 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 20.61 |
Stock-Based Compensation and 60
Stock-Based Compensation and Employee Benefit Plans - ESPP (Details 3) | 3 Months Ended |
Mar. 31, 2018$ / sharesshares | |
Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 0 |
Employee Stock [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares | $ 6.51 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 6 months |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 36.97% |
Stock-Based Compensation and 61
Stock-Based Compensation and Employee Benefit Plans - Stock Options (Details 4) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ 2,100 | $ 1,900 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 1 year 9 months | |
Proceeds from Stock Options Exercised | $ 1,000 | 400 |
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options | $ 2,100 | $ 300 |
Employee Stock Option [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 3,069 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 129 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | 5 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 2,935 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block] | 2,899 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 2,559 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price | $ 8.95 | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | 7.63 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price | 8.99 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | 8.90 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | $ 8.07 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 2 years 4 months 10 days | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 40,641 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 2 years 3 months 29 days | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $ 40,413 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term | 2 years 11 days | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ 37,767 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $ 18.40 |
Stock-Based Compensation and 62
Stock-Based Compensation and Employee Benefit Plans - Additional Information (Details Textuals) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |||
Mar. 31, 2018 | Mar. 31, 2017 | Feb. 28, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 5,500 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 1 year 9 months | |||
Allocated Share-based Compensation Expense | $ 8,473 | $ 5,474 | ||
Shares Issued upon Settlement of Employee Bonus Plan | 300,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ 2,100 | 1,900 | ||
Preferred Stock, Shares Authorized | 25,000,000 | 25,000,000 | ||
Stock Issued During Period, Shares, Employee Stock Purchase Plans | 0 | |||
Proceeds from Stock Options Exercised | $ 1,000 | 400 | ||
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options | 2,100 | $ 300 | ||
Accrued Bonuses | $ 1,800 | |||
Equity Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 13,874,903 | |||
ESPP [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 2,406,646 | |||
Restricted Stock Unit and Restricted Stock Award [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 23.42 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 2 years 3 months 29 days | |||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | $ 47,700 | |||
Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 2 years 3 months 29 days | |||
Common Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Common Stock, Shares Authorized | 550,000,000 | 550,000,000 | ||
Common Class A [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Common Stock, Shares Authorized | 441,124,000 | 441,124,000 | ||
Common Class B [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Common Stock, Shares Authorized | 493,430,000 | 493,430,000 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2009 | Mar. 31, 2018 | Mar. 31, 2017 |
Valuation Allowance [Line Items] | |||||||
Income tax provision (benefit) | $ (1,864) | $ 2,021 | |||||
Unrecognized Tax Benefits, Period Increase (Decrease) | 700 | ||||||
Unrecognized Tax Benefits, Interest on Income Taxes Accrued | 800 | ||||||
Unrecognized Tax Benefits, Income Tax Penalties Accrued | $ 170 | ||||||
State and Local Jurisdiction [Member] | |||||||
Valuation Allowance [Line Items] | |||||||
Open Tax Year | 2,012 | ||||||
Income Tax Examination, Year under Examination | 2,015 | 2,014 | |||||
Foreign Tax Authority [Member] | |||||||
Valuation Allowance [Line Items] | |||||||
Open Tax Year | 2,009 | ||||||
Domestic Tax Authority [Member] | |||||||
Valuation Allowance [Line Items] | |||||||
Open Tax Year | 2,013 | ||||||
Minimum [Member] | |||||||
Valuation Allowance [Line Items] | |||||||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% | ||||||
Maximum [Member] | |||||||
Valuation Allowance [Line Items] | |||||||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 35.00% |
Significant Customer and Geog64
Significant Customer and Geographic Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
Concentration Risk [Line Items] | |||
Long lived assets | $ 558,016 | $ 575,695 | |
Revenue, Net | 110,827 | $ 88,841 | |
Asia [Member] | |||
Concentration Risk [Line Items] | |||
Revenue, Net | 84,814 | 84,332 | |
UNITED STATES | |||
Concentration Risk [Line Items] | |||
Long lived assets | 468,774 | 481,638 | |
Revenue, Net | 5,195 | 145 | |
Rest of World [Member] | |||
Concentration Risk [Line Items] | |||
Long lived assets | 2,055 | 1,643 | |
Revenue, Net | 20,818 | $ 4,364 | |
SINGAPORE | |||
Concentration Risk [Line Items] | |||
Long lived assets | $ 87,187 | $ 92,414 | |
Long lived assets [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Benchmark Description | 1 | 1 | |
Long lived assets [Member] | UNITED STATES | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Benchmark Description | 0.84 | 0.84 | |
Long lived assets [Member] | Rest of World [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Benchmark Description | 0 | 0 | |
Long lived assets [Member] | SINGAPORE | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Benchmark Description | 0.16 | 0.16 | |
Net Revenue [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 100.00% | 100.00% | |
Net Revenue [Member] | Asia [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 77.00% | 95.00% | |
Net Revenue [Member] | UNITED STATES | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 5.00% | 0.00% | |
Net Revenue [Member] | Rest of World [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 19.00% | 5.00% | |
Net Revenue [Member] | Customer Concentration Risk [Member] | Customer A [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 27.00% | 31.00% | |
Net Revenue [Member] | Geographic Concentration Risk [Member] | China [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 61.00% | 78.00% | |
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 10.00% | ||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Pegatron Corporation [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 10.00% | ||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 13.00% | 17.00% | |
United Microelectronics Corporation [Member] | Supplier Concentration Risk [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 21.00% | 21.00% | |
Taiwan Semiconductor Manufacturing Company [Member] | Supplier Concentration Risk [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 19.00% | 19.00% | |
Globalfoundries [Member] | Supplier Concentration Risk [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 14.00% | 17.00% | |
Semiconductor Manufacturing International [Member] | Supplier Concentration Risk [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 15.00% | ||
Vendor D [Member] | Supplier Concentration Risk [Member] | |||
Concentration Risk [Line Items] | |||
Concentration Risk, Percentage | 16.00% | 12.00% |
Commitments and Contingencies65
Commitments and Contingencies (Details 1) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Long-term Purchase Commitment [Line Items] | ||
Operating Leases, Rent Expense, Sublease Rentals | $ 700 | $ 500 |
Lease Expiration Date | Dec. 31, 2023 | |
Contractual Obligation | $ 106,855 | |
Operating Leases | ||
2018 (9 months) | 6,631 | |
2,017 | 9,242 | |
2,018 | 9,444 | |
2,019 | 9,238 | |
2,020 | 5,102 | |
Thereafter | 792 | |
Total minimum payments: | 40,449 | |
Other Obligations | ||
Other Commitment | 17,223 | |
Other Commitment, Due after Fifth Year | 0 | |
Other Commitment, Due in Fifth Year | 0 | |
Other Commitment, Due in Fourth Year | 30 | |
Other Commitment, Due in Third Year | 3,781 | |
Other Commitment, Due in Second Year | 7,761 | |
Other Commitment, Due in Next Twelve Months | 5,651 | |
Contractual Obligation, Due in Second Year | 17,003 | |
Contractual Obligation, Due in Third Year | 13,225 | |
Contractual Obligation, Due in Fourth Year | 9,268 | |
Contractual Obligation, Due in Fifth Year | 5,102 | |
Contractual Obligation, Due after Fifth Year | 792 | |
Contractual Obligation, Future Minimum Payments Due, Remainder of Fiscal Year | 61,465 | |
Inventories [Member] | ||
Other Obligations | ||
2018 (9 months) | 49,183 | |
2,017 | 0 | |
2,018 | 0 | |
2,019 | 0 | |
2,020 | 0 | |
Thereafter | 0 | |
Total minimum payments: | $ 49,183 |
Commitments and Contingencies -
Commitments and Contingencies - Leases (Details 2) - USD ($) $ in Thousands | Nov. 11, 2015 | Dec. 17, 2013 | Mar. 31, 2018 | Mar. 31, 2017 |
Operating Leases, Rent Expense, Sublease Rentals | $ 700 | $ 500 | ||
Operating Leases, Rent Expense, Net | 1,200 | $ 700 | ||
Operating Leases, Future Sublease Income, Remainder of Fiscal Year | $ 2,184 | |||
Lease Expiration Date | Dec. 31, 2023 | |||
Operating Leases, Future Sublease Income, Due in Two Years | $ 3,604 | |||
Operating Leases, Future Sublease Income, Due in Three Years | 4,088 | |||
Operating Leases, Future Sublease Income, Due in Four Years | 4,152 | |||
Operating Leases, Future Sublease Income, Due in Five Years | 879 | |||
Operating Leases, Future Sublease Income, Due Thereafter | 352 | |||
Operating Leases, Future Sublease Income Due | $ 15,259 | |||
The Campus Carlsbad, LLC [Member] | ||||
Lessee Leasing Arrangements, Operating Leases, Term of Contract | 3 years 7 months | |||
Northwest Mutual Life Insurance Company [Member] | ||||
Lessee Leasing Arrangements, Operating Leases, Term of Contract | 6 years 2 months |
Commitments and Contingencies67
Commitments and Contingencies - Litigation (Details 3) $ in Millions | May 16, 2014claim | Oct. 31, 2015claimpatent | Mar. 31, 2018USD ($)claimpatent | Nov. 09, 2016USD ($) |
CrestaTech Technology Corporation v. MaxLinear, Inc. [Member] | ||||
Loss Contingencies [Line Items] | ||||
Loss Contingency, Patents Allegedly Infringed, Number | patent | 2 | |||
Loss Contingency, Allegations | 3 | |||
Patents found not infringed upon | patent | 2 | |||
Inter Partes Review by US Patent Office [Member] | ||||
Loss Contingencies [Line Items] | ||||
New claims filed | 4 | |||
Inter Partes Review by US Patent Office v. CrestaTech Patents [Member] | ||||
Loss Contingencies [Line Items] | ||||
Number of pending claims | 6 | |||
Trango Systems, Inc. v. Broadcom Corporation [Member] | ||||
Loss Contingencies [Line Items] | ||||
New claims filed | 1 | |||
Exar Corporation [Member] | ||||
Loss Contingencies [Line Items] | ||||
Business Combination, Indemnification Assets, Amount as of Acquisition Date | $ | $ 5 | $ 5 | ||
Business Combination, Indemnification Assets, Range of Outcomes, Value, High | $ | $ 13.6 |
Commitments and Contingencies O
Commitments and Contingencies Other (Details) - Exar Corporation [Member] $ in Millions | 3 Months Ended |
Mar. 31, 2018USD ($) | |
Loss Contingencies [Line Items] | |
Release of indemnification asset | $ 0.9 |
Business Combination, Indemnification Assets, Range of Outcomes, Value, High | 13.6 |
Indemnification Agreement [Member] | |
Loss Contingencies [Line Items] | |
Business Combination, Indemnification Assets, Range of Outcomes, Value, High | 136 |
Representations and Warranties [Member] | |
Loss Contingencies [Line Items] | |
Business Combination, Indemnification Assets, Range of Outcomes, Value, High | 34 |
Intellectual Property [Member] | |
Loss Contingencies [Line Items] | |
Business Combination, Indemnification Assets, Range of Outcomes, Value, High | $ 34 |
Subsequent Events (Details)
Subsequent Events (Details) | Mar. 31, 2018 | Nov. 03, 2017 |
Subsequent Event [Line Items] | ||
Derivative, Fixed Interest Rate | 4.25% | 1.74685% |
Restricted Cash (Details)
Restricted Cash (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Dec. 31, 2017 |
Cash and Cash Equivalents [Abstract] | ||
Restricted Cash and Cash Equivalents | $ 1.7 | $ 2.5 |
Revenue from Contracts with C71
Revenue from Contracts with Customers (Details) - USD ($) | 3 Months Ended | |||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Customer contract liabilities | $ 114,000 | $ 0 | ||
Accrued price protection liability | 20,212,000 | $ 21,947,000 | 21,571,000 | $ 15,176,000 |
Revenues | 110,827,000 | 88,841,000 | ||
Connected Home [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenues | 65,658,000 | 77,240,000 | ||
Infrastructure [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenues | 20,490,000 | 11,534,000 | ||
Industrial and multi-market [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenues | $ 24,679,000 | $ 67,000 | ||
Sales Revenue, Net [Member] | Connected Home [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Concentration Risk, Percentage | 59.00% | 87.00% | ||
Sales Revenue, Net [Member] | Infrastructure [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Concentration Risk, Percentage | 19.00% | 13.00% | ||
Sales Revenue, Net [Member] | Industrial and multi-market [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Concentration Risk, Percentage | 22.00% | 0.00% | ||
Price Adjustments [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Accrued customer obligations | $ 0 | |||
Right of Return Asset [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Other Assets | $ 100,000 | |||
Accounts Receivable [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Asset Impairment Charges | $ 0 |